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Abstract  
 
Specificity Determinants of ArmA, a Ribosomal RNA Methyltransferase, that confers 
antibiotic resistance 
By Tamara Zarubica 
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University  
 
Virginia Commonwealth University, 2010 
Major Directors: Dr. H. Tonie Wright  
Professor, Department of Biochemistry and Molecular Biology 
And 
Dr. Jason P. Rife 
Associate Professor, Department of Physiology and Biophysics 
 
     Bacterial resistance to 4,6-type aminoglycoside antibiotics, which target the 30S 
ribosomal subunit, has been traced to the arm/rmt family of rRNA methyltransferases.  
These plasmid-encoded enzymes transfer a methyl group from S-adenosylmethionine to 
N7 of the buried G1405 in the aminoglycoside binding site of 16S rRNA in the 30S 
ribosomal subunit. Neither 16S rRNA alone nor intact 70S ribosome is an efficient 
substrate for armA methyltransferase. To more fully characterize this family of enzymes, 
xiii 
 
 
 
we have investigated the substrate requirements of ArmA.  We determined the Mg
2+
 
dependence of ArmA activity and found that the enzyme could recognize both 
translationally active and translationally inactive forms of 30S subunits.  
To identify the site of interaction between ArmA and the 30S subunit, we used 
hydroxyl radical cleavage of 16S rRNA mediated by ferrous iron chelated to several sites 
on the ArmA molecule that were mutated to cysteine. This data suggests that significant 
conformational changes in 30S structure are involved in binding of ArmA. We 
hypothesized that a precursor intermediate in the biogenesis of the 30S subunit might be 
the optimal substrate for ArmA enzymes in vivo.  To test this, we prepared 30S particles 
partially depleted of proteins by treatment with increasing concentrations of LiCl and 
assayed them for ArmA methylation. Even low concentrations of LiCl alter the 30S 
particles and greatly diminish their susceptibility to methylation. Additionally, a previously 
identified pre-30S particle isolated from an E. coli culture was assayed for its ability to 
support methylation by ArmA and found to be inferior to intact 30S particles as a 
methylation substrate.   
Thus, testing of immature particles prepared from in vitro and in vivo sources 
suggest that ArmA works very late in the 30S biogenesis pathway.  Initiation factor 3 
(IF3), a factor that only binds fully mature 30S particles, does not inhibit the ArmA 
methylation, while kasugamycin methyltransferase (KsgA) abolishes ArmA activity by 
sharing the same binding site with ArmA. From aforementioned experiments, we conclude 
that ArmA is most active toward 30S ribosomal subunits that are at or very near full 
maturation.
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Introduction  
 
Ribosome Assembly  
Ribosomes are complex and dynamic ribonucleoprotein assemblies which provide 
the framework for protein biosynthesis in all organisms. Prokaryotic ribosomes consist of 
two unequal sized subunits; a large 50S subunit and a small 30S subunit. The 'S' refers to 
Svedberg units of the sedimentation coefficient, which measures how fast cell organelles 
sediment in an ultracentrifuge. The larger or more spherical the structure, the higher its 
sedimentation coefficient. Sedimentation coefficients are not additive, so that the 30S and 
50S subunits of an assembled ribosome have a sedimentation coefficient of 70S and not 
80S. All ribosomes share the same general architecture, with small and large ribosomal 
subunits composed of rRNA (~65%) and ribosomal proteins (~35%).  In E. coli, the 
smaller 30S subunit is composed of the 16S rRNA and 21 proteins, while the larger 50S 
subunit contains 23S and 5S rRNAs along with 33 proteins
1
. Ribosome biogenesis, the 
process by which ribosomes are synthesized, is very complex and involves transcription of 
rRNA, pre-rRNA processing, ordered binding of ribosomal proteins and metal ions, 
modification of both rRNA and ribosomal proteins, and sequential conformational 
changes
1
. Furthermore, all of these events have to be tightly regulated and coordinated to 
avoid energy losses and imbalances in the cell.  
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Atomic insights into structural and functional characteristics of ribosomes were 
gained from the high-resolution crystal structures of individual subunits: the small subunit 
from the eubacterium Thermus thermophilus 
2,3
 and the large subunit from the archaeon 
Haloarcula marismortui 
4
 and eubacterium Deinococcus radiodurans
5
. These structures 
were followed by that of the 70S ribosome from T. thermophilus
6
 and E. coli 
7
. The 
structure of T. thermophilus 70S ribosome in complex with release factors RF1 and RF2 
revealed details of interactions of the factors with the ribosome and mRNA
8
.  In addition, 
Selmer et al. solved the structure of T. thermophilus 70S ribosome in complex with tRNA 
and mRNA
9
. All of these structures provide insights into the universal mechanism of 
translation and complex organization of rRNA, ribosomal proteins and ligands. In addition 
to crystal structures, cryo-electron microscopy studies revealed the flexibility of particles 
during translation
10
. 
Even though ribosome biogenesis represents one of the fundamental processes in 
the cell, our understanding of this complex machinery is still somewhat limited. For many 
decades the structural and functional studies of bacterial ribosomes has been intensively 
studied.  The earliest achievements in ribosome study demonstrated that functional 
ribosomal subunits could be reconstituted in vitro using only the component rRNAs and 
ribosomal proteins
11,12
. Following this discovery, 30S subunits were reconstituted using 
either natural or recombinant proteins
13,14
 and in vitro transcribed 16S rRNA, which lacked 
modifications
15
. Particles reconstituted from the recombinant proteins sediment as 30S 
subunits in a sucrose gradient; however, they are less active in tRNA binding and 50S 
ribosomal subunit association than naturally purified ribosomes
12,14
.   
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Multiple experiments reveal that 30S subunit assembly is highly cooperative and 
that ribosomal proteins assemble onto the pre-16S rRNA in a cooperative manner, with 
early binding events organizing the binding sites of late proteins
1
. The small subunit 
ribosomal proteins have been divided into three groups called primary (1
o
), secondary (2
o
), 
and tertiary (3
o
) binding proteins. Reconstitution experiments have demonstrated that 
assembly proceeds with 5' to 3' polarity, which coincides with co-transcriptional protein 
binding
16
, as shown to occur in in vivo ribosomal assembly
17
 (Figure 1a). This indicates 
that the body (5' region) assembles first, followed by platform (central region), and lastly 
the head (3' major region). The final two helices, helix 44 and helix 45, referred to as the 3' 
minor region, assemble along the body and platform regions (Figure 1b).  
Both in vitro and in vivo studies have tried to analyze the pathway of ribosomal 
subunit biosynthesis by identifying reconstitution intermediates. Using the in vitro 
reconstitution system with 16S rRNA and total proteins from 30S subunits (TP30), it was 
determined that at low temperatures (0
o
C to 15
o
C) a particle that sediments as 21S is 
formed; this particle was termed RI, or Reconstitution Intermediate
17,18
 (Figure 2). The 
components of RI are the 16S rRNA and ribosomal proteins: S4-S9, S11-S13, and S15-
S20. Unimolecular conformational rearrangement in the folding of 16S rRNA yields RI*, 
which is a more compact particle of identical composition to RI, with a sedimentation 
coefficient of 26S. The RI to RI* transition is the rate-limiting step in assembly and 
requires either heat (42°) or the presence of the DnaK chaperone system
19
. Once this 
barrier is overcome, remaining ribosomal proteins (S1-S3, S10, S14, and S21) readily 
assemble, even at low temperatures, leading to formation of 30S subunits
17,20
. 
Ribonucleoparticles similar to RI have been observed in vivo, suggesting that the above 
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described in vitro assembly process is valid
21,22
. There are, however, alternative assembly 
pathways observed in vivo. Bubunenko et al. studied the dependence of the in vivo 
assembly pathway for the 30S platform on the ribosomal protein S15, by a deletion of the 
gene for S15
23
. The proteins S6, S11, S18, and S21, which according to the in vitro 
assembly map are dependent on S15 (Figure 1a), were found in normal amounts in purified 
subunits.  
Although the bacterial 30S subunit can be assembled in vitro from its rRNA and r-
protein components
11,14
, this process requires nonphysiological conditions, such as high 
magnesium and monovalent cation concentration
11
. In vivo, however, maturation of rRNA 
and assembly of the r-proteins into a functional ribosome is a highly complex process
24
 
involving multiple accessory proteins
25
. In the case of the 30S ribosome subunit, a group 
of proteins is necessary for the proper processing of the pre-16S rRNA. Apart from the 
nucleases, which are responsible for rRNA cleavage, the in vivo assembly requires the 
presence of the small GTPases Era and RsgA, as well as maturation factors RbfA, RimM, 
and RimN
1
. The absence of these proteins results in the accumulation of 17S, a precursor 
of mature 16S rRNA, which is the product of the RNase III cleavage reaction. While Era 
and RimN are both essential, RimM, RbfA, and RsgA are not essential, at least under 
optimal conditions
26-28
.  
In E. coli, both tRNA and rRNA (except for the 5S rRNA) are covalently modified 
during maturation, including both base and ribose modification
1
. The most common 
modification in rRNA is base methylation, with few other modifications, including the 
isomerization of uridine to pseudouridine.  
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Figure 1. Assembly of the 30S Subunit. (A) In vitro assembly map of the 30S subunit. The 
primary, secondary and tertiary binding proteins are colored black, red and green, 
respectively. S6 and S18 bind as a heterodimer
20
. (B) Domains of the 30S subunit: 5' 
(blue), central (yellow), 3' major (purple) and 3' minor (red). The structure is adopted from 
the E. coli crystal structure
7
 and modeled with PyMol
29
 (www.pymol.org). 
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Figure 2. Prokaryotic ribosome assembly. Structures were modeled using PyMol
29
 
(www.pymol.org)  
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The 16S rRNA contains eleven modified positions, of which ten are base 
methylations, one is a pseudouridine, and one is methylation on the 2'-O of the ribose 
(Figure 3). Although these modifications are not essential for protein synthesis in vitro, 
their localization and conservation suggest that they might be important for folding, 
assembly, or stability of ribosomes in vivo
30
. Most of the modified nucleotides are 
clustered in important functional regions, such as the tRNA binding sites, the decoding 
region, and the mRNA binding area
31 
(Figure 4). All the methyl groups in rRNA are added 
by site-specific methyltransferases, but very limited biochemical data is available 
regarding their mechanism of action. Some modifications, such as m
5
C967 by RsmB and 
m
7
G527 by RsmG methyltransferase, are added to the naked 16S rRNA
32,33
. Other 
modifications are added late during maturation of 30S ribosomal subunits
1
. It is possible 
that the site-specific methyltransferases, which require highly ordered structure and the 
presence of ribosomal proteins for their activity, recognize a certain structure which is 
stabilized by the proteins. Only if the correct structure is present, will modifications occur 
and the assembly process proceed.  
30S Ribosomal Subunit and Its Interaction With Antibiotics 
Antibiotics are natural substances secreted by certain bacteria to protect themselves 
from other bacteria that are competing for limited nutrients. It has been discovered that 
antibiotic producer strains have evolved to protect themselves against self intoxication. 
Later generation of antibiotics used to treat people today are typically derivatives of these 
natural products. Aminoglycosides have been important antibiotics for treatment of serious 
bacterial infections, being especially effective against aerobic Gram-negative bacteria
34
.   
  
8 
 
 
 
 
Figure 3. Examples of modified nucleotides in 16S rRNA. (A) Uridine. (B) Pseudouridine.  
(C) Cytidine. (D) N4, 2’- O dimethylcytidine. (E) Guanosine. (F) N7 methylguanosine. 
Structures were generated using ChemSketch software.  
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Figure 4. Modified nucleotides during 30S ribosomal subunit maturation. Modified 
nucleotides are shown as red spheres, 16S rRNA is shown in orange, ribosomal proteins 
are shown in green, and helix 44 is shown in blue. Decoding region is circled in yellow. 
The structure is modeled using PyMol
29
 (www.pymol.org) 
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Since the structures of whole bacterial ribosome subunits and ribosome-antibiotic 
complexes have been determined, interest in the ribosome as a target for the discovery of 
the new antibiotics has increased rapidly
7,35-37
. These findings have determined very 
precisely the discrete binding sites of several classes of antibiotics inhibiting protein 
synthesis. Three dimensional structures of ribosome-antibiotic complexes reveal that the 
interaction of the antibiotic is predominantly with the RNA components of the ribosome.  
Aminoglycosides are among the most commonly used broad-spectrum antibiotics 
to treat aerobic gram-negative infections, such as severe infections of the abdomen and 
urinary track, bacteremia and endocarditis
38
. Common to all aminoglycosides is the 
neamine core, which is composed of a six-membered cyclitol (2-deoxystreptamine) 
glycosidically linked to a glucopyranosyl. Additional sugars are attached to position 5 or 6 
of the 2-deoxystreptamine moiety to form compounds categorized as 4,5-  or 4,6-
aminoglycosides. Since the amine moieties are mostly protonated under physiological 
conditions, these polycationic species show a binding affinity for nucleic acids and certain 
portions of RNAs, especially prokaryotic rRNA. We are studying the 4,6-aminoglycosides, 
which include but are not limited to, kanamycin, tobramycin, paromomycin, gentamicin 
and geneticin. These interfere with protein biosynthesis by specifically targeting the 
ribosomal decoding  A site (Figure 5) and inducing codon misreading and amino acid 
misincorporation. The crystal structure of the highly conserved decoding site in complex 
with the 4,6-aminoglycoside geneticin (Figure 6) reveals a number of drug-nucleotide 
contacts, showing the important role of the A site in drug binding
36,40
.   
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Figure 5. Secondary structure of 16S rRNA from E. coli
39
.Decoding- A site is shown in red 
box.  
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Figure 6. Interaction of geneticin with nucleotides in the A site
40
. Yellow dashed lines 
represent hydrogen bonds between geneticin (shown in magenta) and A site residues.  
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Aminoglycosides target prokaryotic ribosomes over eukaryotic ribosomes, even 
though the internal loop of A site contains universally conserved nucleotides at six of the 
seven positions
41
. The only difference in sequence of the internal loop is at position 1408, 
which is adenosine in all prokaryotic sequences, but guanosine in all eukaryotic sequences. 
The A1408-A1493 base pair within the aminoglycoside binding site is critical for high 
affinity of antibiotics with rRNA
42,43
. This base pair, along with displacement of two 
adenosines, A1492 and A1493, toward the minor groove, creates a pocket for 
aminoglycosides to bind. The aforementioned bases, together with G1494, are important 
for tRNA binding; hence the binding of aminoglycosides to the A site in the decoding 
region interferes with the accurate recognition of cognate tRNA by rRNA during 
translation
44
.   
The structural basis for aminoglycoside mode of action has also been described 
from the RNA- paromomycin complex, determined by nuclear magnetic resonance 
spectroscopy, which revealed local conformational changes in the prokaryotic A site of 
ribosomal RNA upon drug binding
45
. Binding of paromomycin presumably helps to flip 
out bases A1492 and A1493 (Figure 7a), which are not well ordered in the structure of the 
antibiotic- free 30S subunit
2
 (Figure 7b). It is possible that in the absence of the drug some 
energy is required to flip out A1492 and A1493, so they can contact the tRNA. Most 
likely, this energy is compensated by the formation of favorable interaction with tRNA. By 
binding to the decoding site, 4,6-aminoglycosides provoke a structural rearrangement of 
the decoding site from a state in which it accepts the tRNA to a conformation which is 
productive for peptide bond synthesis even in the absence of cognate mRNA/tRNA 
complex. 
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Figure 7. The decoding A site of the 16S rRNA in the absence of paromomycin
45
 (A) and 
in the presence of paromomycin (B). The two universally conserved residues A1492 and 
A1493 are flipped out of helix 44 in the presence of the drug.  Paromomycin is shown in 
magenta (B). Structures were modeled using PyMol
29
 (www.pymol.org). 
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In the clinical setting bacteria have acquired several resistance mechanisms to 4,6 
disubstituted aminoglycosides, including
46
: (a) deactivation of aminoglycosides by N-
acetylation, adenylylation or O-phosphorylation; (b) reduction of the intracellular 
concentration of aminoglycosides by changes in outer membrane permeability
47
, decreased 
inner membrane transport
48
, active efflux
49,50
, and drug trapping
51,52
; and (c) alteration of 
the 30S ribosomal subunit target by mutation
53
.  
A fourth resistance mechanism is autoprotective in antibiotic producing strains of 
bacteria.  It confers resistance against the toxicity of the bacterium's own secondary 
metabolites through methylation of their ribosomes by genome-encoded 
methyltransferases
54
.  In the presence of S-adenosyl-L-methionine (SAM), post-
transcriptional methylation of specific nucleobases of rRNA in the aminoglycoside binding 
site of these strains blocks binding of aminoglycoside antibiotics and maintains faithful 
protein synthesis. Recently, six distinct but related plasmid borne 30S rRNA 
methyltransferases that confer resistance have been identified in clinical bacterial strains: 
ArmA
55
, RmtA
56
, RmtB
57
, RmtC
58
, RmtD
59
, and RmtE
60
.  All methylate N7 of G1405 and 
thereby confer resistance to the 4,6- di-substituted aminoglycosides
61,62
 (Figure 8). These 
six methyltransferases confer no known physiological advantage in the absence of the 
antibiotics, in contrast to the many endogenous housekeeping methyltransferases that are 
important for the structure and function of mature rRNA. 
It has been shown that the aminoglycoside gentamicin has a high specificity for the 
A site of translationally active 30S ribosomal subunits
37
. Using footprinting experiments, it  
has been observed that the 30S subunit was unable to bind gentamicin as a result of G1405 
methylation by ArmA
61
. The interaction of 30S subunits with gentamicin was probed by 
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Figure 8. Post transcriptional modification of G1405 by Arm/Rmt methyltransferases. The 
figures were generated using ChemSketch Software.    
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chemical modification by dimethylsulfate (DMS) and it was found that 30S subunits 
purified from a strain carrying the armA gene were methylated at G1405. Footprinting of 
m
7
G1405 ribosomes did not reveal protection at G1494, even at 100 mM gentamicin, 
indicating that binding of the antibiotic did not occur. In addition, a mutation in the A site 
hairpin (G1405C/C1496G) disrupted binding of gentamicin (4,6 disubstituted 2-
deoxystreptamine), but did not affect the binding of other classes of aminoglycosides, for 
example paromomycin, a 4,5 disubstituted 2-deoxystreptamine
61
.    
Arm/Rmt m
7
G Methyltransferases  
A significantly increased spread of N7 G1405 methyltransferases among Gram-
negative pathogens has been observed recently.  Galimand et al. found the first gene 
responsible for high-level resistance to 4,6-disubstituted deoxystreptamines and fortimicin 
and  named it aminoglycoside resistance methyltransferase (armA), which encodes a 
putative 16S rRNA m
7
G methyltransferase
55
. Sequence analysis reveals that ArmA belong 
to the ArmA family of methyltransferases, whose hosts are mainly antibiotic producers 
Streptomyces and Micromonospora species, as well as pathogens (Figure 9). The overall 
sequence identity between ArmA and its homologs varies between 21 and 30%, and the 
levels of similarity are between 37 and 47% 
55
. Low guanine-plus-cytosine content of 
armA (30%) distinguishes it from those of antibiotic producing strains, such as grmA 
(65%) and kgmB (71%), which indicates that armA has not evolved from the resistance 
gene in the actinomycetes. However, due to the absence of sequences homologous to armA 
in the data banks, the question remains open as to the identity of the progenitor. The armA 
gene is borne by conjugative plasmid, in which it is flanked by putative transposable 
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Figure 9. Sequence alignment of ArmA from K. pneumonia (Q7WSN7),RmtA from P. 
aeruginosa (Q8GRA1), RmtB from E. coli (Q763K9), RmtC from P. mirabilis (Q33DX5), 
RmtD from P. aeruginosa (A0MK31), KgmB from S. tenebrarius (Q53316), NbrB from S. 
hindustanus (O52472), GrmA from M. purpurea (Q7OKC8), Sgm from M. zionensis 
(Q7MOR2), and FmrO from M. olivasterospora (Q2MFZ2). Identical amino acids in all 
proteins are denoted with a star. The alignment was generated using Clustal X web server.  
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elements. These elements favor dissemination of armA, so it is not very surprising that the 
gene is found in various members of the Enterobacteriaceae family.  
The Arm/Rmt family belongs to a well-characterized group of S- Adenosyl- L- 
Methionine (SAM) dependent methyltransferases, which includes RNA 
methyltransferases, DNA methyltransferases, protein methyltransferases and small 
molecule methyltransferases
63
. This group of enzymes contains a Rossman-like fold, 
which consists of a central β sheet surrounded by a variable number of α helices, and they 
share several conserved motifs
64-66
 (Figure 10). Many of the Rossman-like 
methyltransferases have been well characterized structurally and biochemically, and their 
mechanisms have been explored. In the nucleic acid methyltransferases, the target base is 
flipped out of a stable conformation in secondary structure in order to be methylated. This 
mechanism is found in DNA methyltransferases, whose targets reside within the double 
helix. It is very likely that a similar mechanism is present in the Arm/Rmt 
methyltransferases, where the N7 position of the modified base G1405 is completely 
buried within helix 44
2,7
.  
Arm/Rmt methyltransferases recognize assembled 30S ribosomal subunits as their 
substrates in vitro
61
. Despite the high degree of rRNA conservation in the region of 
methylated G1405, 16S rRNA alone is not an efficient substrate for ArmA
61
. Although 16S 
rRNA is the target molecule of about eleven enzymes, only in two cases can it serve as an 
in vitro substrate. The housekeeping methyltransferases RsmB and RsmG, which 
methylate m
5
C967 and m
7
G527 respectively, are enzymes that can utilize 16S rRNA as in 
vitro substrates
32,33
. More often full or partial assembly is required before full methylation  
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Figure 10. The crystal structure of truncated ArmA
65
 (wheat) superimposed on RmtB
65
 
(magenta) and Sgm
66
 (green). Figures were generated using PyMol
29
 (www.pymol.org).  
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can occur, suggesting that rRNA modification is integrated into ribosome assembly in vivo 
by being able to recognize more complex substrates
67
. In some cases, 30S ribosomal 
subunit in the presence of high Mg
2+
 concentration fails to serve as an efficient substrate, 
possibly indicating that a low Mg
2+
 concentration induced or translationally inactive 
conformation is recognized by the modification enzyme, but the high Mg
2+
 or 
translationally active conformation is not
68
. Biochemical studies indicate that these two 
states are structurally very similar, except in the decoding region
69-71
.  
This dynamic decoding region corresponds to the region of 30S ribosomal subunits 
that has the highest density of modified nucleotides (Figure 4). For that reason, it is not 
very surprising that there is variable access to nucleotides that are to be modified. For 
example, the housekeeping methyltransferase KsgA, which modifies nucleotides A1518 
and A1519, requires relaxation of tertiary interactions between helix 44 and helix 45 to 
methylate the bases
72
.  Likewise, some conformational accommodations on the part of 16S 
rRNA are presumably required for Arm/Rmt to methylate its target nucleotide G1405.  The 
structure of fully formed translationally active 30S ribosomal subunit reveals that G1405, 
the target nucleotide for Arm/Rmt methyltransferases, is buried as a consequence of direct 
tertiary interaction with nucleotide A1518 of the helix 45
2,7
 (Figure 11). The sequestered 
position of the Arm/Rmt target nucleotide G1405 and the heavy traffic of modifying 
enzymes converging on this region, suggest that conformational rearrangement of 16S 
rRNA might be required for these enzymes to access their target nucleotide. Liou et al. 
showed that isolated helix 44, where G1405 lies, is not a possible substrate for ArmA
61
. 
This indicates that Arm/Rmt methyltransferases, as well as modification reactions of 16S 
rRNA during 30S ribosome assembly, are sensitive to a number of solution variables and  
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.   
 
 
 
 
 
 
 
 
Figure 11. Tertiary interaction between G1405 (red sphere) and A1518 (blue sphere). Both 
nucleotides are circled in magenta. Black arrow points to the modified position N7 of 
G1405. Insert shows the hydrogen bonds shared between the same nucleotides. Figures 
were generated using PyMol
29
 (www.pymol.org) 
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assembly states. It is very likely that efficient substrates in many ribosomal modification 
reactions are often some assembly state other than 16S rRNA or 30S ribosomal subunit.    
Unanswered questions 
Aminoglycosides are used extensively for the treatment of severe infections caused 
by Gram-negative bacteria. Recently, however, certain bacterial pathogens have developed 
resistance after acquiring genes for methyltransferases that catalyze post-transcriptional 
methylation of N7-G1405 in the 30S ribosomal subunit. Inactivation of this enzymatic 
activity presents an important challenge and opportunity to develop effective inhibitors that 
will retain the effectiveness of aminoglycoside antibiotics. For that reason, we were 
interested in biochemically and structurally characterizing this group of enzymes in order 
to better understand their mechanism of action.  Recent studies on ArmA homologs have 
opened up intriguing lines of inquiry. However, there is a lack of information about the 
exact mechanism of Arm/Rmt-catalyzed reactions, which is not surprising given the short 
time that this group of enzymes has been studied. One unresolved question is the order of 
substrate binding: Is 30S ribosomal subunit or SAM required to bind first and create the 
binding site for the second substrate?   
In addition, the exact nature of Arm/Rmt’s complex substrate requirements is not 
fully understood. The enzyme cannot methylate the isolated helix 44, 16S rRNA, 50S 
ribosomal subunit or 70S ribosome, but the fully formed 30S ribosomal subunit is 
methylated in vitro
61
. This indicates that Arm/Rmt requires a highly structured 
ribonucleoprotein particle as its optimal substrate, where access is blocked by the 50S 
ribosomal subunit. The window during ribosome biogenesis between free RNA and mature 
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30S subunit when Arm/Rmt can access nucleotide G1405 and transfer the methyl group 
remains to be defined. It was shown that the late acting ribosomal methyltransferase RsmF, 
which methylates m
5
C1407 during ribosome biogenesis, is obstructed by the presence of 
Sgm, an ArmA homolog
73,74
.  In contrast, the two methylations at 16S rRNA nucleotide 
m
4
Cm1402 are unaffected by the presence of Sgm
73,75
. This indicates that Arm/Rmt acts 
later during ribosome biogenesis and that interaction between housekeeping 
methyltransferases and resistance methyltransferases plays an  important role in  Arm/Rmt 
methyltransferases mode of action.  
 
Scope and objectives 
Housekeeping methyltransferases play a role in prokaryotic ribosome maturation 
and are synchronized with rRNA processing, ordered binding of ribosomal proteins and 
conformational changes
31,74,76
.  In 16S rRNA, many of the base modifications are clustered 
in the phylogenetically conserved and functionally essential decoding region of the 30S 
subunit
77
.  The aminoglycoside binding pocket and G1405, the target of ArmA, are located 
within the A-site of the decoding region and are flanked by several methylated nucleotides: 
C1402, C1407, U1498, A1518, and A1519.  This tight clustering very likely imposes an 
evolved order of methylation steps to avoid methyltransferase crowding and possible 
obstructive stereoelectronic effects to downstream methylations introduced by the 
modifications.  Such constraints would require synchronization of ArmA with the other 
housekeeping methyltransferases. The sequestered position of the Arm/Rmt target 
nucleotide G1405 in the crystal structure of the 30S subunit and the heavy traffic of 
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modifying enzymes converging on this region
78
, suggest that conformational 
rearrangement of 16S rRNA might also be required for these enzymes to access their target 
nucleotide.  
Given that very limited biochemical data has been reported on the function of this 
group of enzymes, this study is intended to further investigate the Arm/Rmt mechanism of 
action. The substrate specificity and requirements of ArmA were investigated to both 
characterize the enzyme and to resolve the conundrum of how they interact with their 
target nucleobase. We determined the Mg
2+
 dependence of ArmA activity and the effects 
of gentamycin, kasugamycin resistance methyltransferase (KsgA) and initiation factor 3 
(IF3) binding to 30S subunits on ArmA activity.  We also tested LiCl treated 30S particles 
and in vivo derived pre-30S ribosomal subunits as ArmA methylation substrates. We find 
that very late steps in 30S ribosomal maturation are prerequisites for these 
methyltransferases to carry out their modification reaction, since the best substrate for 
ArmA is a highly structured ribonucleoprotein particle, very close in conformation to the 
fully mature 30S substrate.  Conformational changes, either very late in the pathway of 
30S ribosomal subunit assembly or off-pathway, appear to be necessary for Arm/Rmt 
methyltransferase to access the completely buried G1405.  
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Cloning, Production, and Initial Characterization of Arm/Rmt Enzymes 
For proteins to be analyzed using informative structural methods such as X-ray 
crystallography or NMR, they have to be highly soluble and stable over a reasonable 
period of time. While sometimes proteins of interest behave in this way, more often protein 
purification can be challenging and difficult. Preparation and expression of proteins can 
have many obstacles, such as protein aggregation and proteolytic degradation.  Protein 
insolubility at higher concentration can present problems, especially if the aim of the study 
is to structurally characterize the protein.  In order to improve the yield of soluble protein, 
many strategies are used, including the optimization of protocols for expression and 
purification of proteins, or expressing the desired proteins in alternative host cells.  
The purification and expression of the ribosomal methyltransferase, RmtA, was 
initially undertaken for purposes of structural characterization of this group of enzymes.  
Pseudomonas aeruginosa pJ31:6303- rmtA was synthesized chemically (DNA. 2.0 Inc.) to 
incorporate NdeI and XhoI cleavage sites for cloning.  These enzymes (New England 
Biolabs) were used for digestion of the synthetic DNA and the resultant fragments were 
ligated into the plasmid vector pET15b, which had been digested with these same enzymes 
(NdeI and XhoI).  Escherichia coli XL1-Blue (Stratagene) was transformed with the 
ligation mixture and transformants were selected on Luria-Bertani agar plates 
supplemented with 30 mg/ml of kanamycin.  
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The pET15b-rmtA plasmid containing an N-terminal His-tag coding region was 
isolated using a Qiagen Mini-prep kit. The correct ArmA sequence was confirmed by the 
Nucleic Acid Research Core Facility at Virginia Commonwealth University.  The plasmid 
was transformed into both HMS17 and BL-21(DE3) cells for protein production, but only 
the latter produced colonies.  This construct gave very low RmtA expression, so other 
plasmid constructs made by cloning rmtA into pET20-b, pET21-c and pET31-b, were 
tested for better RmtA expression. Unfortunately, these three constructs showed even 
lower expression compared to the pET15-b- rmtA, with most of the enzyme being in 
inclusion bodies. Even when the enzyme was produced under conditions of lower 
temperatures at 18
o
C/ 25
o
C or lower concentration of IPTG (0.1 mM), the solubility of 
RmtA did not change significantly. In the end, the original pET15b N- terminal His-tag 
construct yielded the most soluble protein of the three constructs, but the enzyme remained 
too unstable at higher concentrations (>5 mg/ml) to be amenable to structural 
characterization. Even the use of multiple solubility screens, such as different pH and salt 
concentrations, failed to increase protein solubility enough to screen for crystallization.    
Escherichia coli DH10B+ pJ210:10629- rmtC was also obtained from DNA 2.0 
Inc.  NdeI and XhoI (New England Biolabs) were used for digestion of the synthetic DNA 
and the digest ligated into the plasmid vector pET29-b, which carries a C-terminal His tag 
coding region.  E. coli XL1-Blue (Stratagene) was transformed with the ligation mixture, 
and transformants were selected on Luria-Bertani agar plates supplemented with 100 
mg/ml of ampicillin and 30 mg/ml chloramphenicol. The sequence of isolated pET29b-
rmtC plasmid was confirmed by the Nucleic Acid Research Facilities at Virginia 
Commonwealth University. However, RmtC engineered with a C-terminal His-tag showed 
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low in vitro methylation activity.  This may be due to the His - tag affecting the correct 
folding of the protein or the binding of the two substrates, 30S ribosomal subunit and S –
Adenosyl-L-Methionine (SAM). Therefore, the rmtC gene was ligated into pET15b, which 
contains an N-terminal His-tag coding region. The correct rmtC sequence was confirmed 
by Nucleic Acid Research Facilities at Virginia Commonwealth University. RmtC was 
over-expressed with 1 mM IPTG and purified by Ni-NTA affinity chromatography. 
Protein purification attempts were made more difficult by insolubility of the overexpressed 
RmtC, so purification conditions were optimized for production of soluble protein.  Under 
different buffer conditions, RmtC was not stable in the absence of at least 10% glycerol 
and reducing agent, either dithiothreitol (DTT) or β-mercaptoethanol (BME).  Even under 
these conditions, the protein precipitated out when stored for more than one week at 4°C. 
Acinetobacter baumannii pUCarmA1-armA construct was obtained from Dr. Yohei 
Doi, of the University of Pittsburgh School of Medicine. The gene encoding armA was 
inserted into pET15b as an NdeI-XhoI fragment with an N-terminal His tag.  The correct 
ArmA sequence was confirmed by Nucleic Acid Research Core Facility at Virginia 
Commonwealth University.  The plasmid was transformed into BL-21(DE3) cells for 
protein production. ArmA was overexpressed with 1 mM IPTG, purified by Ni-NTA 
affinity chromatography eluting with 0.3M Imidazole. Protein was estimated to be >95% 
pure using SDS-PAGE analysis and stable for at least a few weeks at 4
o
C. Since ArmA 
with an N- terminal His-tag showed improved stability relative to the Rmt constructs over 
a longer period of time, we decided to conduct our future experiments using this enzyme. 
In vitro activity assays confirmed that the correct enzyme was purified (see below).  
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In vitro Analysis 
The relative enzymatic efficiency of RmtA, RmtC and ArmA in methylation of E. 
coli wild type 30S ribosomal subunits in an in vitro activity assay was determined. 
Substrate 30S subunits were prepared from wild type E. coli as described in the 
experimental section.  Incorporation of 
3
H-methyl from labeled SAM by each enzyme was 
measured after an incubation of one hour.  Negative control experiments were performed 
with 30S subunits in the absence of enzymes. Also, the same assay was attempted in the 
absence of 30S ribosomal subunits, but in the presence of methyltransferases. All 
experiments were performed with 10 pmol of 30S substrate and 10 pmol of enzyme. In 
vitro activity assays for RmtA and RmtC showed somewhat lower final incorporation of 
3
H- SAM compared to ArmA (Figure 12). This might be due to the solubility problems 
seen for RmtA and RmtC. It is likely that the enzymes started forming aggregates during 
the in vitro assay (as was also noticed during the purification step) leaving only a fraction 
of soluble RmtA/RmtC available to methylate the 30S ribosomal subunit.  Another reason 
for differences in incorporation of 
3
H-methyl from labeled SAM could be the use of 
different 30S ribosomal subunit preparations. Nevertheless, it seems that ArmA is simply 
more efficient than the other two enzymes.   
The Arm/Rmt enzymes transfer only one methyl group from the SAM molecule to 
guanosine 1405. The exact mechanism of transfer has not yet been established. Question 
remains as to a preferred order, if any, of substrate binding. So, our next question was to 
see if the order of substrate addition for the 30S ribosomal subunit and SAM would 
influence the incorporation of 
3
H from the labeled SAM by ArmA (Figure 13 A). All 
experiments were performed with 10 pmol of 30S substrate and 10 pmol of enzyme, and 
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the data was fit using logarithmic curve. With stoichiometric amounts of protein relative to 
30S, the time-course of methylation was essentially indistinguishable among the different 
experiments, confirming that the order of substrate addition did not influence the final 
level of methylation. In addition, the rate of incorporation of methyl group does not change 
when substrates are added in a different order (Figure 13B). This result is, however, open 
to interpretation. Due to the complex mechanism, it is possible that the addition of the 
second substrate, but not the first one, represents the slow step in the reaction. In our 
experiment, we were limited in detecting only the net chemical reaction, so additional 
methods might be necessary to determine which step in the reaction is rate - limiting.  
Mg
+2
 Dependence of ArmA Activity 
It is known that the conformational state of the 30S ribosomal subunit is sensitive 
to the concentration of Mg
+2
 and NH4Cl
79,80
. High Mg
+2
 concentrations stabilize an active 
state of 30S, while low concentrations of Mg
+2
 stabilize a translationally inactive 
conformation of the 30S subunits 
69
.  It has been determined that ArmA is active in 
methylating 30S ribosomal subunits at higher concentration of Mg
+2 61
. In order to further 
explore the magnesium dependence of ArmA activity, we varied the concentration of this 
divalent cation in our assays (Figure 14A). The broad plateau of maximal ArmA activity in 
the range of 10 - 15 mM Mg
+2
 indicates that the enzyme methylates the translationally 
active form of the 30S subunit.  However, ArmA retains 1/2 of its maximal activity at 4 
mM Mg
+2
, where the translationally inactive form of the 30S subunit predominates, 
suggesting that ArmA recognizes both the translationally active and inactive forms.  
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Figure 12. In vitro methylation of 30S by RmtA (A), RmtC (B), and ArmA (C). All 
reactions were performed for 1 hour at 37 °C in Buffer ‘R’ and contained 3H-SAM.  
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Figure 13. In vitro methylation of 30S subunit. Time-course assays for ArmA (A) 
measured over 90 minutes. Blue diamond indicates assays containing 10 pmol 30S added 
first, then 10 pmol enzyme, and SAM ; red square indicates assays containing 10 pmol of 
enzyme added first, then SAM and 10 pmols 30S; green triangle indicates assays 
containing 10 pmol 30S added first, then SAM and 10 pmols of enzyme; purple cross 
indicates assays containing 10 pmol of enzyme added first, then 10 pmol 30S and SAM. 
Blue star indicates assays containing SAM added first, then 10 pmol 30S and 10 pmol of 
enzyme; orange circle indicates assays containing SAM added first, then 10 pmol of 
enzyme and 10 pmol 30S. (B) In vitro methylation assay measured in the first 10 minutes. 
The data was fit using logarithmic (A) or linear (B) curve. The same legends applied as in 
the part (A). 
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As a further test of whether ArmA recognizes the low Mg
+2
 translationally inactive 
form of the 30S subunit, we utilized kasugamycin resistant (ksg
R
) 30S subunits, which lack 
methyl groups on A1518 and A1519.  On the basis of the known tertiary interaction 
involving modified nucleotides A1518/A1519 with helix 44, these methylations are 
expected to stabilize the active conformation of the 30S subunits and their absence should  
increase the proportion of translationally inactive form in the low Mg
+2
 concentration 
transition range
2,7
. The Mg
+2
 dependence of ArmA activity is similar for the wild type and 
ksg
R
 forms of 30S subunit at high Mg
+2
 concentrations: both have broad maxima centered 
around 8 – 10 mM.  However, the activity profile for the ksgR substrate (Fig. 14B) is 
skewed to significantly higher activity at lower Mg
+2
 concentrations (4 - 6mM) than the 
wild type. While the Mg
2+
-dependence of ArmA activity is somewhat sensitive to the 
presence of A1518 and A1519 methylation, it is clear that ArmA is capable of recognizing 
both the inactive and active forms of 30S subunits. Mathew Baker from our lab also tested 
the ArmA ortholog RmtA for activity in the presence of low and high Mg
+2
 concentrations 
and obtained similar results (data not shown).  
Conclusions  
Arm/Rmt enzymes identified in clinical strains post-transcriptionally methylate 
nucleotide G1405 at the N7 position in the presence of SAM, and confer resistance to the 
4,6-disubstituted aminoglycosides
61,81
. These methyltransferase enzymes provide no 
known physiological advantage in the absence of the antibiotics and in that sense they 
differ from many endogenous, housekeeping methyltransferases, which are important for 
both the structure and function of the rRNA
1
.  
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Figure 14. Effect of Mg
2+
 on Arm activity. In vitro methylation of wild-type 30S (A) and 
ksg
R
 30S (B) 
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The decoding region of E.coli 16S rRNA alone, where the modified G1405 lies, 
contains several nucleotides that are methylated by endogenous methyltransferases, such as 
C1402
75
, C1407
74
, and U1498
67
. With all of these bulky methyltransferases operating in 
this small region of 16S rRNA, it is difficult to picture another enzyme finding its way to 
modify G1405.  Substrate recognition by the Arm/Rmt methyltransferases might be 
complex. Arm/Rmt is able to methylate 30S ribosomal subunit in vitro, but it does not 
methylate either 70S ribosome or 16S rRNA
61
. In addition, isolated helix 44 is not an 
efficient substrate for ArmA
61
, proving that the enzyme recognizes structured 
ribonucleoprotein in vitro. The reported kcat value for ArmA
61
, 0.2 min
-1
 is comparable to 
turnover numbers for RsmE
67
, 0.042 min
-1
 and RrmJ
82
, 0.064 min
-1
, indicating that ArmA, 
like RsmE and RrmJ, might require highly assembled ribosomal particles for methylation. 
In contrast to ArmA, RmsB and RlmD methyltransferases have significantly higher 
turnovers in vitro: 2.6 min
-1
 and 3.6 min 
-1
, respectively
32,83
. However, this is somewhat 
expected, since these latter enzymes act on free rRNA and may not require highly 
structured substrates.  If we take into account that the time required for 30S subunit 
maturation in vivo has been reported to be only a few minutes, ArmA does not act very 
slowly in vivo
84
.  It is clear from the 30S crystal structure that G1405, the target nucleotide 
for Arm/Rmt methyltransferases, is buried as a consequence of direct tertiary interactions 
with nucleotides A1518 and A1519 of helix 45
7
. It has not been confirmed if there is an 
obligate order to substrate binding to allow ArmA to access the buried nucleotide.  Enzyme 
binding to 30S subunits most likely requires either conformational rearrangement of 16S 
rRNA or the substrate that we use for an in vitro study is different in some way from the 
one that is modified during ribosome assembly in vivo. Our results demonstrate that ArmA 
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is able to methylate both active and inactive conformations of 30S ribosomal subunits in 
vitro, and that the order of substrate addition does not influence the final level of 
methylation. However, the complexity of the Arm/Rmt methyltransferases imposes the 
need to further explore and understand their mechanism of action.  
Experimental  
Cloning 
 A synthetic rmtA gene was obtained from DNA 2.0. The 776 base-pair rmtA gene 
was amplified by PCR using the following primers, purchased from Integrated DNA 
Technologies: 5’-CTG ACT GCA ATA TGA GCT TTG ACG ATG CCC-3’ and 
5’- CTG CCT CGA GTC ACT TAT TCC TTT TTA TCA TGT ACA C-3’. The gene was 
cloned into the pET15b vector (Novagen) as an NdeI/XhoI fragment for expression as an N 
terminal His tagged fusion construct. The recombinant plasmid was sequenced (Nucleic 
Acids Research Facilities, VCU) to confirm the presence and correct sequence of the 
insert. 
A synthetic rmtC gene was obtained from DNA 2.0. The 879 base-pair rmtC gene 
was amplified by PCR using the following primers, purchased from Integrated DNA 
Technologies: 5’- ATA CAT ATG AAA ACC AAC GAT AAT TAT ATC GAA -3’ and 
5’- ATA CTC GAG TCA CAA TCT CGA TAC GAT AAA ATA CAT-3’. The gene was 
cloned into pET15b vector (Novagen) as an NdeI/XhoI fragment for expression as a His 
tagged fusion construct. The correct clone was confirmed by sequencing (Nucleic Acids 
Research Facilities, Virginia Commonwealth University).  
Acinetobacter baumannii pUCarmA1-ArmA construct was obtained from Dr. 
Yohei Doi, from the University of Pittsburgh School of Medicine and was confirmed by 
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sequencing. The gene encoding armA was inserted into pET15b as an NdeI-XhoI 
fragment. The isolated pET15b-armA plasmid contained N-terminal His-tag coding region. 
The correct ArmA sequence was confirmed by the Nucleic Acid Research Facilities at 
Virginia Commonwealth University.   
Protein expression and purification 
pET15b-RmtA and pET15b-RmtC plasmids were transformed into BL-21 (DE3) 
Rosetta II cells for overexpression. Cell cultures were grown to an OD600 of 0.6 in the 
presence of ampicillin and chloramphenicol and induced with 1 mM IPTG (Sigma-
Aldrich). After 4 hours at 37ºC, cells were harvested by centrifugation. Pellets were 
resuspended in lysis buffer (50 mM NaPO4, 500 mM NaCl, 10 mM imidazole, 10 % 
glycerol, 1 mM DTE pH 7.5), broken with two passages through an Emulsiflex cell 
breaker (Avestin), and centrifuged to remove cell debris. Cleared lysate was loaded onto a 
HiTrap Chelating column (Amersham) equilibrated with 0.1M NiSO4, washed with lysis 
buffer and the proteins were eluted with elution buffer (50 mM NaPO4, 500 mM NaCl, 
300 mM imidazole, 10% glycerol, 1 mM DTE pH 8.0). 
The pET15b-ArmA plasmid was expressed in BL21 (DE3) cells (Stratagene). The 
cells were grown at 37ºC to an OD600 of 0.6 in the presence of ampicillin. The protein 
was induced with 1 mM IPTG and transferred to 37ºC for 4 hours. Cells were harvested 
and broken as for RmtA and RmtC.  Purification was carried out by affinity 
chromatography using a Ni-NTA chromatography column; buffers were the same as 
above. Proteins were estimated to be >95% pure by SDS-PAGE analysis. Protein 
concentration was measured using the absorbance at 280 nm and the extinction coefficient, 
using protein calculator v3.3, for each protein. (http://www.scripps.edu) 
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30S purification 
For in vitro activity assay, 30S ribosomal subunits from the MRE600 strain of E. 
coli were prepared as described
85
.  For 30S subunits lacking methylation at A1518 and 
A1519, an MRE600 strain resistant to the antibiotic kasugamycin were used
86
. Subunits 
from this strain are referred as 30S-ksg
R
.  
Wild-type purified subunits were dialyzed into reaction buffer (40 mM Tris, pH 
7.4; 40 mM NH4Cl; 8 mM MgOAc; 1 mM DTE) and stored at –80ºC in single-use 
aliquots. The ksg
R
 purified subunits were dialyzed into reaction buffer (40 mM Tris, pH 
7.4; 40 mM NH4Cl; 4 mM MgOAc; 1 mM DTE) and stored at –80ºC in single-use 
aliquots. 30S concentration was estimated by measuring the absorbance at 260 nm and 
using a relationship of 67 pmol 30S per 1 unit of optical density. 
In vitro analysis 
The in vitro assay was adapted from Poldermans et al. (1979). Time-course reactions were 
performed in 50 µl volumes containing 40 mM Tris, pH 7.2, 40 mM NH4Cl, 8 mM 
MgOAc, 1 mM DTE, 0.02 mM 
3
H-methyl-SAM (780 cpm/pmol; MP Biomedicals), 10 
pmol 30S subunits, and 10 pmol enzyme. Buffer and reagents were pre-warmed to 37ºC 
and added into pre-warmed tubes to minimize any lag in the reaction start. At each of the 
designated time points 10 µl of 100 mM unlabeled SAM (Sigma- Aldrich) was added to 
tubes to quench the reaction. The quenched reactions were deposited onto DE81 filter 
paper (Whatman), washed twice with ice-cold 5% TCA, and rinsed briefly with ethanol. 
Filters were air-dried for one hour, placed into scintillation fluid, and counted.  
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ArmA Interaction With its Substrates - 30S subunit and 
S-Adenosyl-L-Methionine 
 
Introduction 
 
The interaction between ArmA and 30S subunit is complex and details of the 
mechanism of ArmA action are not known, in part because of the limited biochemical data 
on this group of enzymes. Neither 16S rRNA alone nor 70S ribosome is a substrate for 
Arm/Rmt methyltransferases, while assembled 30S subunit is methylated by purified 
ArmA in vitro 
61
. If we examine  the crystal structure of fully formed translationally active 
30S subunits, we notice that the target nucleotide G1405 is  sequestered from the surface 
and is  inaccessible for modification by ArmA 
2,7
 (Figure 15). However, Agarwal et al, 
using cryo-electron microscopy revealed that the 30S subunit is conformationally flexible, 
with the conformational changes mainly localized in the neck, the platform and shoulder 
regions
10
.  Since the ArmA target nucleotide lies in helix 44, a highly flexible region of 
30S, the enzyme presumably induces a conformational change required for the methylation 
of G1405. It is also possible that the mechanism of ArmA action includes the flipping out 
of the modified base G1405. Base flipping has been documented for both DNA- and RNA-
modifying enzymes and is believed to be the dominant mechanism used by these enzymes 
to access target bases that are normally inaccessible due to secondary and/or tertiary 
interactions in the nucleic-acid molecule
87
.  
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Figure 15. Modified nucleotide G1405 (circled in red) in the 30S ribosomal subunit. The 
16SrRNA is shown in orange and the ribosomal proteins are shown in grey. The red arrow 
points toward the buried N7 position of G1405. Structures were generated using PyMol
29
. 
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To gain a better understanding of the complex mode of ArmA action, we undertook 
investigation of the ArmA interaction with the 30S ribosomal subunit. Directed hydroxyl 
radical probing, followed by primer extension analysis, was used to investigate ArmA 
interaction with its substrate 30S ribosomal subunit
88,89
. Directed hydroxyl radical probing 
generates low resolution (10–50 Å) information about the part of a nucleic acid that is in 
the vicinity of a defined site on a protein or other nucleic acid
90
. This approach has been 
used to study the 16S rRNA environment around individual ribosomal proteins in the 30S 
subunit
88,91
, elongation factors
92
, initiation factors
93
, release factors
94
, ribosome recycle 
factors 
95
, and ribosomal methyltransferases
72
. This approach was used to explore the sites 
of interaction between ArmA and 30S subunit to determine the specific contact regions 
between the two.  
 
Results  
 Directed Hydroxyl Radical Probing  
To probe 16S rRNA with hydroxyl radicals, Fe(II) is tethered to specific positions 
on the surface of a protein by reaction of the Fe(II)-loaded linker, 1-(p-
bromoacetamidobenzyl)-EDTA
96,97
 with unique cysteine residues. To produce ArmA with 
different unique single cysteine residues, the only naturally found cysteine in ArmA at 
position C115 was mutated to alanine. This mutant with no cysteine (cys-less) was used as 
our control sample and served as background when comparing the other cleavage sites on 
the primer extension gel. The cys-less mutant was used to construct double mutants and to 
insert single cysteine residues at positions 43, 59, 64, 190, 220, and 234 (Y43C, Y59C, 
L65C, V190C, M220, G234C). These positions on ArmA are shown in Figure 16.  
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Figure 16. ArmA cysteine mutants. Backbone atoms of residues which were mutated to 
cysteine are shown as spheres. Y59C is yellow, L65C is orange, C115 (wild type) is cyan, 
V190C is blue, and G234C is magenta. Y43C is not shown in the figure since the N 
terminal truncated form of ArmA58 was used. The structure was generated using PyMol
29
. 
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We chose these specific residues based on several criteria. First, we wanted to 
mutate residues that were not conserved in ArmA, thus limiting the likelihood that they 
would interfere with protein folding and function.  Second, we wanted to mutate residues 
that are surface exposed and readily accessible to solvent. Lastly, we chose residues that 
were widely spaced throughout ArmA, so that the information we gained from the 
hydroxyl radical experiment would not be redundant. Before starting the experiment, we 
checked in vitro methylation activity of each mutant and found that all except one, ArmA 
C115A M220C, could fully methylate 30S subunit (Figure 17). We discontinued working 
with this ArmA double mutant, since it precipitated out during purification steps. The six 
selected mutants were purified as previously described in Chapter 2.  
In this technique, hydroxyl radicals are generated locally from Fe(II) tethered to a 
single position in ArmA,  resulting in cleavage of the rRNA backbone at positions  
proximal to the Fe(II) ion.  Because of the short lifetime of hydroxyl radicals in aqueous 
solution, cleavage is usually restricted to positions in the RNA that are within about 10 Å 
of the Fe(II) ion
88
. Fe(II) is tethered to the unique cysteine residue at specific sites in  
ArmA via 1(p-bromoacetamidobenzyl) -EDTA (BABE), a reagent that has been 
successfully used to map intramolecular distances in proteins
98
.  Iron-derivatized ArmA is 
incubated with a fully formed 30S subunit to create a complex (Figure 18). Once the 
complex between ArmA and 30S subunit is formed, hydroxyl radicals are generated by the 
Fenton reaction in the presence of H2O2 and ascorbic acid 
99
. After cleavage the RNA is 
extracted from the 30S subunits, annealed with labeled primers, and analyzed by primer 
extension, an extremely sensitive technique for detecting breaks in the RNA backbone 
(Figure 19).  
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Figure 17. In vitro activity assay of ArmA cysteine mutants. 
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Figure 18. Site directed hydroxyl radical probing. Single cysteine residues (shown as 
yellow spheres) are mapped onto the ArmA structure (A). Fe(II)- BABE is attached to each 
single cysteine residue, represented as a black star (B). ArmA single cysteine residues are 
incubated with 30S subunit to form a complex (C). In the presence of H2O2 and Ascorbic 
acid, hydroxyl radicals are generated to cleave 16S rRNA backbone (D).  
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Figure 19. Primer extension. Cleaved 16S rRNA is first annealed with radio labeled 
primers and then extended using reverse transciptase in the presence of free nucleotides. 
The product is analyzed on sequencing gel as shown in Figure 20.  
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In this work, synthetic DNA oligomers were used to anneal to target RNA template 
sequence and prime DNA polymerization by reverse transcriptase. These primers were 
generally 17 nucleotides long and were complementary to a single region of the target 
16S RNA. Cleavages of the RNA were indicated by the appearance of additional bands, 
above background, in the autoradiogram, which represent abortive cDNA transcripts 
ending at the position of RNA template cleavage. Portions of the RNA backbone which are 
in proximity to the Fe(II) will be cleaved more often than positions which are further away. 
Therefore, more cleavage events occurring at a particular site correspond to a heavier band 
on the gel. Figure 20 shows representative autoradiograms, which include two dideoxy 
sequencing lanes, a control cys-less ArmA lane and experimental lanes from the ArmA-
Fe(II) mutants. Autoradiography of the gel with Kodak Hyperfilm was typically carried out 
overnight at room temperature. However, the length of time required for appropriate 
exposure varied for different primers. Cys-less ArmA is considered to be the background 
for the other lanes, since the bands appearing in this lane do not correspond to direct 
probing. Band intensities are correlated with the distance between the RNA target and the 
position of the Fe(II) on ArmA. When probing was initiated from Fe(II)-modified ArmA 
proteins (Figure 16) bound to the active 30S subunit, both unique and in some instances 
overlapping, cleavage patterns were obtained from three of the six Fe(II)- derivatized 
ArmA proteins.  
RNA Footprinting Analysis of ArmA Interaction With the 30S Subunit 
To identify the site of interaction between ArmA and the 30S subunit, hydroxyl 
radical probing initiated from Fe(II) - modified ArmA proteins bound to the E. coli 30S 
subunits was performed as described above. For this experiment, different primers were 
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used to scan the whole 16S rRNA, but only primers 480, 939, and 1257 showed 
reproducible cleavages (Figure 20). The cleavage patterns obtained from different Fe(II) - 
derivatized ArmA proteins show little similarity and are somewhat dispersed throughout 
the 16S rRNA with no evidence of  clustering at a specific site on 30S subunit. Cleavages 
were seen in helices 25 and 34, in the loops of helices 14 and 15, and in the base of helices 
24, 25 and 27 (Figure 21). In addition, we observed cleavage sites along helix 44, but the 
helix 44 results were not reproducible when the probing was repeated, so the data were 
excluded.  
When the cleavage data were mapped onto the structure of the three – dimensional 
fully mature 30S subunit
7
, we noticed multiple binding sites dispersed around the modified 
nucleotide G1405 (Figure 22A). Some of the cleavages, such as the ones seen in helices 24 
and 27, were more than 30 Å away from the modified nucleotide G1405. In addition to 
these distal sites, cleavages were detected on the opposite face of the 30S ribosomal 
subunit relative to the target nucleotide, close to the binding site of the ribosomal protein 
S15 (Figure 22B).  However, the most surprising cleavages identified from this experiment 
were completely buried inside helix 34 and inaccessible to ArmA in the translationally 
active 30S conformation.  In addition, we observed cleavage sites along the helix 44 (data 
not shown); however, the helix 44 results were not reproducible when the probing was 
repeated. It should be noted that these experiments were performed in the absence of S- 
Adenosyl Homocysteine (SAH) as a surrogate second substrate (inhibitor). However, the 
presence of this second ‘substrate’ is unlikely to be critical for ArmA binding to the 30S 
subunit, since similar ambiguous results were obtained for Sgm footprinting experiments,  
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Figure 20. Primer extension analysis of directed hydroxyl radical cleavage of 16S rRNA in 
the translatioanally active 30S subunits from Fe(II)-ArmA. Cleavage sites and the 
sequence numbers of nucleotides within 16S rRNA are denoted by bars on left and right of 
figures, respectively.  A and G are sequencing lanes; Fe(II)-ArmA–30S complexes are: 
Cys-less, a Fe(II)-BABE treated cysteine-free mutant of ArmA; Fe(II)-Cys43-ArmA; 
Fe(II)-Cys59-ArmA; Fe(II)-Cys65-ArmA; Fe(II)-Cys115-ArmA; Fe(II)-Cys190-ArmA; 
Fe(II)-Cys234-ArmA. Primers are 480 (A), 939 (B and C) and 1257 (D). 
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Figure 21. Directed hydroxyl radical cleavage sites from Fe(II)-ArmA (shown in boxes) on 
the secondary structure of 16S rRNA 
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Figure 22. Directed hydroxyl radical probing mapped on the30S subunit from ArmA. The 
cleavage sites are shown on the three dimensional structure of E.coli 30S structure
7
 (A) 
and include 180
o 
rotation view of the same figure (B). The modified nucleotide G1405 is 
circled in red.  
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which were done in the presence of 1 mM SAH
66
. The multiple and dispersed binding sites 
seen in the Sgm-30S complex, observed at helices 24, 42,43, and 44, indicate that  SAH 
does not influence binding of ArmA (or Sgm) to the 30S subunit.  
This ambiguous pattern of ArmA interaction with the 30S subunit could be due to 
binding at multiple non-specific sites and/or to large conformational changes in the 30S 
subunit upon ArmA binding.  ArmA is a monomer under the conditions used for these 
experiments, which excludes the possibility of extended oligomers modifying at sites 
remote from the methylation site
61
.  The data obtained from this experiment correlate well 
with the results reported by Husain et al., where chemical footprinting with CMCT 
(specific for nucleotides G and U) and DEPC (specific for nucleotide A) were carried out 
on E. coli 30S subunits to determine the sites of interaction between 30S and the 
sisomicin-gentamicin methyltransferase Sgm, an ArmA homolog
66
. In contrast to the 
ArmA – 30S binding sites, Sgm cleavages extended to helix 44, where the modified 
nucleotide G1405 lies. They reported that conformational changes occur in the 30S 
subunit, upon its interaction with Sgm, that allow the enzyme to access the target 
nucleotide G1405, which is otherwise buried in the crystal structure of 30S subunit
66
. 
To gain insight into possible ArmA and target - base interactions, we tried to build 
a model using the program PyMol
29
. However, we were not able to position G1405 into the 
active site of the ArmA – SAM complex due to multiple close contacts. First, we tried to 
build the ArmA -30S model using the crystal structure of fully formed translationally 
active 30S ribosomal subunit
7
. In this 30S structure, the modified base was completely 
sequestered in the helix 44 and was not accessible to ArmA for transfer of the methyl 
group. Second, our directed hydroxyl radical data revealed that ArmA reached mostly the 
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solvent – exposed face of helices. This implied that the target base was never closer than 
20Å to the methyl group of SAM.  Third, even if we minimized the distance between the 
methyl group of SAM and the target nucleotide, the base would need to be rotated out of 
helix 44 and N7 position of G1405 exposed to the surface. This base flipping mechanism 
would be similar to the ones seen in DNA and RNA modifying enzymes that access target 
bases that are normally not accessible due to secondary and/or tertiary interactions in the 
nucleic acid molecule
100
. Lastly, the largest limitation in building the model was the 
number of dispersed binding sites that we observed in our hydroxyl radical data 
experiment, especially the ones found very distal from the modified nucleotide G1405.  
Binding of ArmA to 30S and SAM  
In spite of the wealth of literature on rRNA methylation, the structural information 
currently available for RNA methyltransferases is insufficient to elucidate their mechanism 
of action. Even though directed hydroxyl radical data revealed a very weak and multiple 
non- specific binding of ArmA to 30S subunit (Figure 22), we were curious to further 
explore the binding interactions between ArmA and its substrates. Assuming that the 
absence of SAM does not effect the binding of ArmA to 30S subunit, we decided to 
determine the affinity of ArmA for each substrate separately. One of the methods used to 
study the physical basis of molecular interactions between enzyme and substrates is 
isothermal titration calorimetry (ITC). ITC provides a direct way to the complete 
thermodynamic characterization of protein interactions. In one ITC experiment we can 
physically measure the heat generated or absorbed during a binding reaction (ΔHobs). The 
typical experiment involves addition of one binding partner (titrant) to the other binding 
partner (titrate) over time using one or more individual injections (Figure 23).  
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Figure 23. A schematic diagram of a typical isothermal titration calorimeter.  
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Here, heat is measured as the change in power required for maintaining temperature 
between the sample and a reference cell. Then, a binding enthalpy is calculated based on 
knowledge of the cell volume and the concentration of the reactants. The observed 
enthalpy measured in an experiment includes not only the heat of binding between the 
molecules, but also any additional heat sources associated with the reaction, including 
solvent effects, molecular reorganization and conformational changes, and heats of dilution 
resulting from sample stirring. The heat produced during each injection is proportional to 
the amount of complex formed, so maximal changes in enthalpy occur at the earliest points 
in a titration with a decrease in magnitude as free titrant is consumed. Since all equilibrium 
constants vary with temperature, according to van’t Hoffs equation (1), we can calculate 
the affinity constant: 
d lnK/ dT = ΔH/ RT2                   (1) 
where R is the gas constant, T is the absolute temperature. An equilibrium constant is also 
related to the Gibbs free energy (ΔG) of binding by the reaction (2): 
ΔG = - RT ln Ka     (2) 
Since the ΔHobs is measured directly from the ITC experiment, we can also calculate the 
reaction entropies (ΔS) from the reaction (3): 
ΔG = ΔH –TΔS     (3) 
The complete thermodynamic characterization can be obtained from a single ITC 
experiment, which makes this technique very widely used. With modern ITC 
instrumentation, sample requirements are greatly reduced, which makes this method 
applicable to study RNA biochemistry, among other systems. One other benefit of using 
this method is that it does not require labeling of the protein or substrates, which might 
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interfere with ArmA folding or binding to the 30S subunit. Because of its benefits and 
simplicity, we decided to implement the ITC technique to determine the binding of ArmA 
to its substrate.  
First, we titrated ArmA with S- Adenosyl-L-Methionine (SAM). ArmA showed 
clear binding to SAM, with an affinity in the low micromolar range, 45.8 ± 0.00147 µM. 
The fit for this titration produced reasonable stoichiometry, with N equal to 1.02 ± 0.138, 
indicating one SAM molecule bound per protein. The injection profile and the integration 
(heat release) for each injection (except the first one) are shown in the figure 24.  The solid 
dots indicate the experimental data. The best fit to the experimental data, integrated 
response versus molar ratio of ligand added, was obtained using a single site fitting model 
from Origin 7.0 software (OriginLab Corp). The result was in agreement with a Kd value 
of 18 µM obtained for Sgm, ArmA ortholog, binding SAM
66,101
. In addition, the binding 
constant was similar to the Kd value for RsmC, which methylates m
2
G1207 in 16S rRNA 
(Kd 4.8 µM)
102
.  It is important to note that Kd
SAM
 is very similar to Km
SAM
 (40 ±15 µM)
61
, 
which indicates that SAM is bound with comparable affinity in the binary complex and in 
the presence of 30S subunits.  
Our next goal was to determine the dissociation constant for ArmA and 30S 
subunit, since it has not been reported. Since ITC has been successfully used for measuring 
the binding between the 30S and small molecules
103
, we assumed that determining the 
binding of ArmA to 30S subunit would not be any different. However, the absence of any 
previously reported ITC measurements between a protein and a ribosomal subunit 
foreshadowed the encountered complications. Only one such (unsuccessful) experiment 
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has been reported and that was the attempt to measure the binding of the housekeeping 
methyltransferase RsmC, which methylates m
2
G1207
102 
, to 30S subunit.   
The thermodynamics of ArmA – 30S interactions were measured using the VP – 
ITC 200 calorimeter. Mature 30S subunits were placed in the sample cell and ArmA in the 
syringe. Both solutions were extensively dialyzed in the same buffer solution containing 40 
mM HEPES (pH 7.5), 40 mM NH4Cl, 8 mM Mg acetate, 10% glycerol and 6 mM BME.  
The concentration of 30S was varied from 2 µM to 10 µM while the ArmA concentration 
was 10 to 20 times higher than the 30S subunit to insure saturation. Assays were attempted 
at 20
o
C or 37
o
C.  The spacing between injections was 300 seconds to insure baseline 
equilibration after each ArmA sample addition.  
Numerous failed trials to measure the binding of ArmA to 30S ribosomal subunits 
prompted the conclusion that ITC for whatever reason is not suited for this task.  Figure 25 
shows different isothermal titration calorimetric measurements for ArmA and 30S subunit. 
From these experiments, we notice that saturation of 30S by ArmA does not occur, even 
when an excess of ArmA (twenty times) was used to ensure the completion of the reaction. 
Control experiments verified that the large signals observed were not artifacts. In this case, 
ArmA was titrated into the buffer (previously described) to ensure that the interaction 
between ArmA and the buffer does not compensate the heat change between ArmA and 
30S subunit. In this experiment, we noticed a very small change in the heat transfer, 
indicating that the ArmA dilution effect was negligible. We also tested the ArmA – ArmA 
interaction to ensure that ArmA did not aggregate and cause a large false signal. Once 
again, we did not observe a large heat change when ArmA was titrated into ArmA.  
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Figure 24. Isothermal titration calorimetric analysis of SAM binding to ArmA. (A) 
Titration of SAM (via syringe) into the ArmA protein (sample cell); (B) The binding 
isotherm fit to a model of a single SAM binding site. 
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Figure 25. Isothermal titration calorimetric analysis of 30S subunit binding to ArmA. A) 
Titration of ArmA (via syringe) into the 30S subunits, in ratio 10:1. Figures (A) and (B) 
depict two different experiments (from different 30S and ArmA preparations) 
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Therefore, the ITC analysis for ArmA/30S binding appears valid, yet cannot be explained 
by a simple bimolecular reaction. To ensure the analysis was performed with active ArmA 
and 30S subunits, both were tested and confirmed active in a standard in vitro 
methyltransferase assay (Figure 26).  The 30S subunits were fully methylated in the 
presence of ArmA and both the enzyme and the substrate were active when the ITC 
experiments were performed. However, it remains a mystery as to why the 30S/ArmA 
binding data cannot be simply fit to standard binding models.  
To ensure that 30S subunits do not stick to the wall of the sample cell and prevent 
binding, we reversed the reaction and titrated the 30S into the ArmA (placed in the cell). In 
this experiment, we varied the concentration of ArmA from 2 to 10 µM and the 30S from 
15 to 40 µM. The experiment was performed at 37
o
C to ensure the same conditions would 
be followed as for the in vitro activity assay. The spacing between injections was 300 
seconds to ensure enough time for equilibration. The first titration was 0.5 µL followed by 
fifteen 2.5 µL injections (Figure 27).  Results were identical to those seen in Figure 25, 
where we did not observe the saturation of ArmA by 30S subunits even when they were in 
the vast access. 
Finally, the question remains of whether or not SAM is required before ArmA can 
bind 30S subunit. Since SAM could not be used in this experiment (methylation would 
occur) the product SAH was used, but the data showed the same curve as for the previous 
experiments (Figure 28A). In the course of conducting the attempt to measure the binding 
reaction, we also measured the thermodynamic contribution of the methyl transfer reaction. 
To 30S subunits and SAM placed in the cell, we titrated ArmA and SAM; however, the 
analysis revealed nearly identical results to all previous ArmA/30S experiments (Fig. 28B). 
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Figure 26. In vitro methyltransferase activity assay of ArmA. Assays were performed in 
triplicate; error bars represent standard deviation.  
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Figure 27. Isothermal titration calorimetric analysis of ArmA titrated into 30S ribosomal 
subunit.  
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Figure 28. Isothermal titration calorimetric analysis of 30S binding to ArmA in the 
presence of SAH (A) and SAM (B). 
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One possible explanation for the results obtained might be that ArmA does not bind 
to the 30S subunit very tightly and hence we do not observe the interaction; however, we 
observed heat changes during the reaction.  Another possibility is that ArmA binds to 30S 
at multiple binding sites, which is consistent with the results obtained from the directed 
hydroxyl radical probing experiments (Fig 22), thus making it difficult to interpret the 
binding using the ITC method.  
Fluorescence Polarization Anisotropy  
The second method used to determine the Kd of ArmA and 30S subunit was 
fluorescence polarization (anisotropy). This method is widely used for measuring the 
binding interactions between two molecules, and it can be used to determine the binding 
constant (or the dissociation constant) for various interactions. In this technique, a 
fluorophore attached to one of the molecules is excited by polarized light. This absorption 
of light by a population of molecules induces electron passage from the singlet ground 
electronic level S0 to an excited state Sn (n>1).  An excited molecule will return to the 
ground state via emission of a photon (fluorescence), which is measured with a polarizer as 
a polarized light. Fluorescence polarization is defined by the following equation (4): 
 
P = (IV – IH) / (IV + IH)         (4) 
 
where P equals polarization, IV equals the vertical component of the emitted light, and IH 
equals the horizontal component of the emitted light of a fluorophore when excited by 
vertical plane polarized light. However, if the molecule is moving, the polarization of the 
light will be reduced by radiation in a different direction from the incident light (‘scramble’ 
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effect)
104
. This effect is greatest with fluorophores freely tumbling in solution and 
decreases with decreased rates of tumbling. Upon binding of fluorescently labeled ArmA 
to the 30S subunit, tumbling of the fluorophore will reduce, thus increasing the amount of 
polarized light detected. The effect should be particularly large given the relative 
molecular weight of ArmA (~30,000 D) and the 30S subunit (~900,000 D).   
In our experiment, ArmA was fused to fluorescein-5 –maleimide at the sulfhydryl - 
containing cysteine residue. We used the previously described ArmA C115A G234C 
double mutant for fluorophore attachment at C234, since this residue was exposed to the 
surface and accessible for labeling. By titrating 30S subunits (from 1 to 2,000 nM) into the 
50 nM ArmA, attempts were made to measure changes in polarization, which should be 
proportional to the amount of ArmA – 30S subunit complex formed. However, we were 
unable to detect the binding of ArmA to 30S over the concentrations tested (Figure 29A). 
To determine if the presence of SAM was necessary for ArmA – 30S complex formation, 
we repeated the experiment in the presence of 1 mM Sinefungin (a natural SAM analog). 
As in the ITC experiments, the presence of a SAM surrogate did not affect the outcome 
(Figure 29B).  
At this point, the question remains open as to the order of substrate addition. Our 
ITC and fluorescence anisotropy experiments do not confirm that the binding of SAM to 
ArmA is a prerequisite for ArmA – 30S complex formation. The best evidence for that 
would be the crystal structure of ArmA in complex with its substrates; however, only two 
structures of methyltransferases, RumA and TrmA, in complex with their respective RNA 
substrates have been solved
105,106
. The one unsuccessful attempt to obtain evidence for the 
nucleotidic substrate binding site for Arm/Rmt group of enzymes was by soaking the  
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Figure 29. Fluorescence anisotropy for ArmA and 30S in the absence (A) and presence of 
1 mM Sinefungin.  
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RmtB- AdoMet crystals in a solution containing GMP
65
. However, the structure of RmtB – 
GMP complex revealed that the base and ribose binding sites exactly match those observed 
for SAM; i.e. the nucleotide G1405 occupies the binding site of the SAM and not the target 
guanosine in the 16S rRNA.  
Conclusions 
We measured the binding constant of ArmA and its substrate, S- Adenosyl- L- 
Methionine by ITC method and found the dissociation constant to be 45.8 µM. We were 
unsuccessful in determining the binding constant of ArmA and 30S subunits using two 
different methods. It is very possible that the translationally active 30S ribosomal subunits 
used in our experiments do not bind very tightly to ArmA; hence, we are not able to detect 
the binding using aforementioned methods.  However, the same 30S subunits are capable 
of being methylated in the presence of ArmA, as shown in our in vitro activity assay. This 
implies that the mechanism of action is complex for this group of enzymes. For that reason 
we decided to create a minimal kinetic scheme for Arm/Rmt methyltransferases to help us 
understand the complexity of this group of enzymes (Figure 30). High Mg
+2
 concentrations 
stabilize an active state of 30S, while low concentrations of Mg
+2
 stabilize a translationally 
inactive conformation of the 30S subunits, represented here as 30S* (k1/k-1 step)
69
.  We 
have shown (in Chapter 2) that ArmA, in the presence of SAM,  can recognizes both forms 
of 30S subunits and transfer the methyl group to the N7 position of G1405 (k5 step). Once 
the guanosine nucleotide becomes modified, the product (SAH) is released (k6 step). We 
took into consideration a possible conformational change in 16S rRNA upon methylation 
of G1405, which could lead to the formation of different conformation of 30S subunit,  
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Figure 30. Minimal kinetic scheme of ArmA methylation of 30S subunit. Translationally 
inactive 30S subunit is represented as 30S*, possible conformation of methylated 30S 
subunit is represented as 
me
30S**.  
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represented here as 
me
30S** (k-11 step). Since rRNA methyltransferases have not been 
extensively characterized, one of the experiments to be considered in the future could be to 
try and trap a more stable ArmA/30S/SAM complex. This way the methylation step would 
be stalled and the complex would be stable enough to measure the rate of binding. This 
could be done by having an ArmA mutant which would be catalytically inactive but able to 
bind to the 30S subunit.     
Directed hydroxyl radical probing experiments revealed that ArmA binds very 
weakly to its substrate, 30S ribosomal subunit. At this time, we are unable to build a model 
of ArmA – 30S complex that would satisfactorily explain all our footprinting data. 
Cleavage sites more distal to G1405, even at the opposite face of the ribosome relative to 
the target nucleotide, suggest that ArmA binds 30S subunits weakly, and possibly non-
selectively. Hence, conformational changes that are expected to occur in 16S rRNA upon 
ArmA binding are most likely complex and involve multiple rearrangements of spatially 
distant elements that probably have a global character. Data indicate that the mechanism of 
action for the ArmA group of enzymes is complex and has to be studied in detail by 
measuring discrete steps of the process. Only when more biochemical data become 
available will it be possible to design specific inhibitors to treat infections due to bacteria 
resistant to 4,6 - disubstituted aminoglycosides.  
Experimental  
Mutagenesis 
Primers were designed which contained the mutations of interest flanked by 15-20 
bases of wild-type sequence (Table 1). Mutagenesis was performed using the Stratagene 
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QuikChange Kit according to the manufacturer’s protocol. Briefly, wild-type plasmid was 
denatured and the primers were annealed and extended by thermal cycling with PfuTurbo 
DNA Polymerase (Stratagene). DpnI (Stratagene) was used to digest the parental (non-
mutant), naturally methyalted DNA. The plasmids were then transformed into E. coli XL1-
Blue cells and ArmA mutants were confirmed by sequencing. 
Protein and 30S Subunits Expression and Purification 
Proteins and 30S subunits were expressed and purified as described in Chapter 2.  
Activity Assay 
In vitro activity assay was performed as described in Chapter 2.  
Hydroxyl radical probing experiment 
Hydroxyl radical probing experiment was performed under the supervision of Dr. 
Gloria Culver, as described
89
. 
Preparation of Fe(II)-BABE derivatized ArmA 
Fe(II)-BABE complex was formed as previously described by Xu et al. (2008)
72
.  
In brief, 3 nmol ArmA (cysteineless or cysteine-substituted) were incubated with 70 nmol 
Fe(II)-BABE in BABE modification buffer (1 M KCl, 80 mM K
+
-Hepes, pH 7.6, 0.01% 
Nikkol) in 100 ul total volume at 37°C for 30 minutes. Excess Fe (II)-BABE was removed 
from derivatized ArmA by centrifugation at 5000 rpm in Microcon (10,000D cutoff) 
centrifugal concentrators at 4 °C followed by additional washes with 400 µl BABE 
modification buffer. 
Formation of ArmA/30S subunit complexes 
The formation of the ArmA/30S complex was done essentially as described
72
.  In 
brief, 30pmols submethylated 30S subunits were incubated with 150 pmols Fe(II)-ArmA 
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in buffer containing 40 mM Tris, pH 7.2, 40 mM NH4Cl, 8 mM MgOAc, 1mM DTE  in 
100 µl total volume at 37 °C for 1 hour.  Unbound Fe(II)-ArmA proteins were removed 
using Sephacryl S-200 spin columns at 2000 rpm for 3.5 min.  
Primer extension analysis 
Directed hydroxyl radical probing was done essentially as described by Culver and 
Noller
89
 (2000). Specific ArmA – 30S complexes, 4 µl Fe-EDTA solution, 2 ul 5% 
hydrogen peroxide and 2 ul 500 mM ascorbic acid were added in a total volume of 100 ul.  
Reactions were performed on ice and quenched by adding 40 µl 0.1 M thiourea. Each 
experiment was performed at least three times to insure that data were reproducible. 
Extracted 16S rRNA was analyzed by primer extension as previously described by Stern et 
al. (1988)
107
. Cleavage intensities were compared to the intensity of control sequencing 
lanes.  
Isothermal titration calorimetry  
Isothermal titration calorimetry was performed as described
66,101
. ArmA in  40 mM 
HEPES (pH 7.5), 40 mM NH4Cl, 8 mM Mg acetate, 10% glycerol and 6 mM BME was 
titrated against SAM solution prepared by dissolving the appropriate amount of SAM in 
the same buffer. The ITC experiment was carried out on a VP - ITC 200 calorimeter 
(Microcal, LLC) at 20
o
C using 0.02-0.1 mM protein in the sample cell and 1-2 mM SAM 
in the syringe. All samples were degassed and centrifuged prior to use. Measuring the heat 
of dilution for the ligand involved a single 0.5 µL injection, followed by either 1.5 µL or 
2.5 µL injection volumes of SAM  (depending on the number of injections) with 300 
seconds spacing between the injections required for the baseline to equilibrate. 
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Fluorescence Polarization Anisotropy 
ArmA C115A G234C mutant was labeled with Fluorescein 5- Maleimide in the buffer 
containing 20 mM sodium phosphate, pH 7.5, and 150 mM NaCl. We added EDTA at a 
final concentration of 5 mM to prevent metal-catalyzed formation of disulfide bonds.  We 
used 25-fold molar excess of Fluorescein 5 –Maleimide over the molar amount of ArmA to 
be coupled. The reaction was allowed to proceed for 30 minutes at 30
o
C. Non-reacted 
fluorescein was removed by desalting. The change in polarization was measured by 
titrating 30S subunits (from 1 to 2,000 nM) into the 50 nM ArmA, using TECAN 
Polarizon. 
 
Table 1. Primers for Active site mutants 
 
 
 
 
 
 
 
  
73 
 
 
 
 
ArmA Methylation of Variant Forms of 30S Ribosome 
Subunits and 16S rRNA 
LiCl Treated 30S Ribosomal Particles 
Introduction 
In the presence of high concentrations of monovalent salts, such as CsCl, LiCl, or 
NH4Cl, the ribosomal proteins dissociate from the 30S subunit producing a series of 
protein deficient ribosomal particles with different sedimentation coefficients
108
. This 
dissociation is primarily the result of a weaker association of proteins on the RNA scaffold 
due to the suppression of their electrostatic interactions in the presence of higher ionic 
strength. Both during incubation at a high salt concentration and with stepwise increase in 
ionic strength, groups of proteins sequentially dissociate from the particles, resulting in the 
formation of a series of protein-deficient derivatives
108,109
. In the presence of 1M LiCl, 
protein-depleted particles sediment as 25S, while higher LiCl concentrations (1.5, 2.0. 3.0 
or 3.5 M) produce particles that sediment as 23S, 21S, 19S and 16S, respectively
108
. The 
stepwise dissociation of ribosomal proteins from E. coli 30S subunit with increasing LiCl 
or CsCl concentration is schematically shown in Figure 31. Initially, at low salt 
concentration, loosely bound proteins dissociate first, followed by the more strongly bound 
core proteins. The order of protein dissociation by LiCl or CsCl roughly reflects the order 
of their assembly into the 30S subunit
13,14
 (Figure 32).  
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Figure 31.Scheme of the disassembly of the 30S ribosomal subunit achieved by high 
concentration of LiCl
108
.  
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Figure 32. In vitro assembly map of the 30S subunit. 16S is shown on the top. Arrows 
indicate interactions between components. The primary, secondary and tertiary binding 
proteins are colored black, red and green, respectively. The S6 and S18 bind as a 
heterodimer
13,14
. 
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Results  
ArmA recognizes and methylates mature 30S ribosomal subunits, but not phenol-
chloroform extracted 16S rRNA
61
. The question remains as to what the minimal number of 
ribosomal proteins required for ArmA methylation in vitro is.  In an attempt to answer this 
question, 30S ribosomal subunits were prepared by incubation with increased 
concentration of LiCl using the procedure of Itoh et al (1968)
108
.  The protein depleted 
particles were isolated using sucrose gradient sedimentation and measured for their methyl 
acceptor activity. We found that treatment of mature 30S subunits with even low 
concentrations of LiCl (up to 0.75M) led to a sharp decrease in susceptibility to 
methylation (Figure 33A). The 30S subunits treated with 1M LiCl showed a very low level 
of methyl acceptor activity, while no activity was seen for subunits treated with higher 
concentrations of LiCl.  The decrease in ArmA activity is attributed to ribosomal protein 
loss, since a 2% agarose gel containing formaldehyde confirmed that 16S rRNA was not 
degraded during preparation of subunits at any of the LiCl concentrations used (Figure 
33B).  
We further analyzed subunits treated at low concentrations of LiCl (0 to 1M) for 
changes in the composition of their associated proteins (Figure 34).  Since the ArmA 
activity decreased slightly in the presence of 0.5M LiCl, we sought to identify the 
ribosomal protein(s) dissociated in this range of LiCl concentration, which are likely to be 
required for the full activity of ArmA. Qualitative two dimensional acrylamide gel 
electrophoresis revealed that at low LiCl concentrations (up to 1 M), treated subunits retain 
the same complement of ribosomal proteins as the LiCl untreated sample, even though 
their susceptibility to methylation by ArmA drops significantly (Figure 33A). 
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Figure 33. In vitro methylation of LiCl-treated 30S ribosomal subunits (A). A 2% agarose gel 
containing formaldehyde, confirming that 16S rRNA is not degraded (B) 
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0 M LiCl
1 M LiCl0.75 M LiCl
0.5 M LiCl
 
Figure 34. Two dimensional acrylamide gels showing ribosomal proteins isolated from the 
LiCl treated particles.  
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It is important to note that the ribosomal protein S6 was not measured in this 2D gel 
system, because of its acidic PI
110
.  However, from Figure 31, we note that the ribosomal 
protein S6 is expected to come off in the higher LiCl concentration and would not 
influence the decrease in ArmA activity when lower concentrations of LiCl treated 
particles were used. Even subunits treated with 1 M LiCl, where methylation activity is 
almost completely abolished, show no significant subtraction of any of the 30S proteins.  
Although this experiment provides only a qualitative assessment of the protein 
complement of LiCl treated 30S subunits, the sharp difference in ArmA activity between 
0.5 M LiCl and 0.75 M LiCl particles (Figure 33A) in the absence of any detectable 
difference in protein content (Figure 34) argues against a role for the proteins in the 
observed loss of ArmA activity.  
The dissociation of most of the proteins from the ribosomal particles does not 
appear to disrupt the overall tertiary structure and compactness of the RNA
111,112
. Electron 
microscopy experiments reveal that removing half of the proteins does not lead to 
significant morphological changes in the particles. When a fragment of the 16S rRNA 
(corresponding to the central domain) and five proteins S6, S8, S11, S15 and S18 was 
examined by electron microscopy, the isolated particles had an appearance that was similar 
in size and shape to the corresponding morphological features of the 30S subunit
111
. In 
contrast, our experiments imply that the decrease in ArmA activity is likely due to changes 
induced by the LiCl in the 16S rRNA.  Structural support for the possibility of a significant 
conformation change in the helix 44/45 region comes from cryo-EM studies of the 
complex RbfA with 30S ribosomal subunits
113,114
. To further test our observation, the 30S 
subunits treated with varying concentrations of LiCl were incubated in high Mg
2+
 buffer 
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with 50S subunits and showed a progressive decline in the yield of 70S with increasing 
concentration of LiCl used to treat the 30S subunits (Figure 35).   This result, taken with 
the activity assays for the LiCl treated subunits (Figure 33A), indicates that even at low 
concentrations of LiCl, only a fraction of the particles are in a conformation that can 
function as an ArmA substrate.   
Pre-30S Ribosomal Particles as ArmA Substrates 
The 16S rRNA undergoes covalent modification, primarily methylation, at a 
number of sites during maturation of the 30S ribosome subunit.  For the methyltransferase 
RsmB, protein-depleted 16S rRNA can serve as an in vitro substrate
32
.   A larger number 
of methyltransferases, e.g. RsmC, RrmJ, KsgA (RsmA)
31
, RsmF
74
, RsmH, and RsmI
75
  
require a more complex substrate than the naked 16S rRNA for methylation to occur.  In 
the E. coli 30S
7
 ribosomal subunit crystal structure, many of the nucleotides that are 
methylated are clearly not accessible to modification enzymes, including those for which 
the mature 30S subunit serves as a substrate
78
.  Some of these may be modified in vivo 
during the maturation process when subunit intermediates offer functional substrates to the 
modifying enzymes
76
.  Others may reflect inherent lability in parts of the 30S subunit that 
permits transient access to sites that are otherwise sequestered in the most stable form of 
the assembly.  The region of the 16S rRNA with the highest density of nucleotide 
methylation targets is around the mRNA decoding site, which is known to be structurally 
dynamic
77
.   
It has been shown that the modification at m
5
C1407 by the housekeeping 
methyltransferase RsmF is impeded as Sgm, an ArmA homolog, gains access to the 
nucleotide G1405
73
. In contrast, the two methylations at nucleotide m
5
Cm1402  
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Figure 35. Sucrose gradient for 30S LiCl-treated subunits assembled with 50S ribosomal 
subunits into 70S ribosome. 30S subunit treated with (A) 0M LiCl, (B) 0.5M LiCl, (C) 
0.75M LiCl, (D) 1M LiCl assembled into 70S by incubation with 50S ribosomal subunits.  
Peak number one corresponds to 30S ribosomal subunit; peak number two corresponds to 
50S ribosomal subunit; peak number three corresponds to 70S ribosome.  
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(RmsH and RsmI) are unaffected by the presence of Sgm, indicating a requirement for 
local changes in the structure of the 30S subunit when these modification enzymes bind to 
and modify mature 30S subunits, together with a specific order for methylations of 
nucleotides in 30S subunits
73
.  
We tested pre-30S subunits, which do not assemble into 70S ribosomes, as 
potential ArmA substrates. The pre-30S subunit sediments as fully formed 30S and 
contains 17S rRNA, a precursor of 16S rRNA, which is the product of the RNAse III 
cleavage that separates small subunit rRNA from the remainder of the primary 
transcript
1
(Figure 36). Further processing of 17S rRNA by RNAses E, G, and a still 
uncharacterized RNase produce the mature 5' and 3'ends
1
. Small GTPases Era
26
 and 
RsgA
27
 as well as RbfA, RimM
28
, and RimN
1
 proteins are required for proper processing 
of the pre-16S rRNA. The absence of these proteins may impair 17S processing by 
interfering with 30S assembly and accumulating pre-30S subunits. However, 
characterization of pre-30S subunits remains incomplete. It is still an open question which 
ribosomal proteins, housekeeping methyltransferases, and ribosomal binding factors are 
present in the pre-30S subunits. However, it has been determined that the loss of 
methyltransferase KsgA alters 16S rRNA processing and accumulation of pre-30S 
subunits
76
. Even though it has been determined that ArmA recognizes fully formed 30S 
61
, 
we were interested in investigating if the pre-30S ribosomal particles could serve as a 
substrate.  
Fully formed 30S ribosomal subunits were separated from the pre-30S subunits on 
a sucrose gradient following the procedure of Connolly et al. (2008)
76
. For this experiment 
we used Keio collection cells in which ksgA was deleted (E.coli strain JW0050-3)
115
 to 
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avoid possible inhibitory effects of bound KsgA on ArmA
76
 (see below and Connolly et al. 
(2008)). The pre-30S subunits were measured for methyl acceptor activity by 
3
H 
incorporation from 
3
H- SAM (Fig. 37) relative to a control of fully formed 30S ribosomal 
subunits prepared from 70S ribosomes isolated from the same ∆ksgA strain. Our results 
show that pre-30S subunits are sub-optimal substrates for ArmA in vivo.  
Our data imply that the optimal substrate for ArmA in vivo is structurally 
significantly different from the pre-30S subunit. This outcome is not very surprising if we 
take into consideration that even a small change in 16S rRNA conformation affects ArmA 
activity and that an almost fully formed 30S subunit is required for the enzyme to transfer 
a methyl group to G1405.  
Conclusions 
 
To determine whether limited depletion of proteins from the 30S subunit affects 
ArmA methylation activity, we prepared 30S ribosomal subunits by incubation with 
increasing concentrations of LiCl, using the procedure of Itoh et al. (1968)
108
. We found 
that treatment of mature 30S subunits with even low concentrations of LiCl (up to 0.75M) 
led to a sharp decrease in susceptibility to methylation. The 30S subunits treated with 1M 
LiCl and sedimenting at 25S
108
 showed a very low level of methyl acceptor activity, while 
no activity was seen for subunits treated with higher concentrations of LiCl (Figure 33A). 
This experiment implies that the decrease in ArmA activity is due to changes induced by 
the LiCl in the 16S rRNA.  This is supported by the observation that 30S subunits treated 
with varying concentrations of LiCl when incubated in high Mg
2+
 buffer with 50S subunits  
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Figure 36. Schematic of rRNA processing in E. coli
1,7
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Figure 37. In vitro methylation of pre-30S subunits and 30S subunits from 70S ribosomes 
at 37
ס
C and 25
ס
C as ArmA substrates. 
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showed a progressive decline in the yield of 70S with increasing concentration of LiCl 
used to treat the 30S subunits (Figure 35).   This result taken with the activity assays for 
the LiCl treated subunits indicates that even at low concentrations of LiCl, only a fraction 
of the particles are in a conformation that can function as an ArmA substrate.   
We also tested whether ArmA can methylate pre-30S subunits, which do not assemble 
into 70S ribosome.  Our results show that these pre-30S subunits are sub-optimal substrates 
for ArmA in vivo. We conclude that ArmA requires a highly structured ribonucleoprotein 
particle as a substrate for methylation, and the methylation event in the 3' minor domain of 
16S rRNA occurs late during 30S ribosome assembly.  
Experimental  
Protein and 30S Subunits Expression and Purification 
Proteins and 30S subunits were expressed and purified as described in Chapter 2.  
Activity Assay 
In vitro activity assay was performed as described in Chapter 2.  
LiCl salt washes of 30S subunits 
Protein-depleted 30S ribosomal subunits were obtained by treatment with 
increasing concentrations of LiCl according to Itoh et al. (1968)
108
. Briefly, 30S subunits 
were diluted into buffer (20 mM Tris-HCl, pH 7.8, 100 mM Mg(OAc)2 and 1 mM DTE) at 
final LiCl concentrations of 0M, 0.5M, 0.75M, 1M, 1.25M, 1.5M, 1.75M, or 2M.  Samples 
with concentrations of LiCl higher than 1M were incubated overnight at 4°C; others were 
prepared just prior to centrifugation.  LiCl-washed particles were pelleted by centrifugation 
at 45,000 rpm in a Beckmann 70Ti rotor for 6.5h and a sucrose sedimentation profile was 
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performed as described (Basturea et al, 2007)
67
.  Pellets were re-suspended in buffer 
containing 20 mM Tris-HCl, pH 7.8, 0.1 mM Mg(OAc)2, 1 mM DTE and isolated on a 10-
30% sucrose gradient by centrifugation in a Beckmann SW28 rotor at 25,000 rpm for 17 
hours. Peak fractions were collected, concentrated by centrifugation through an Amicon 
Ultra 30K cutoff filter, and stored at -80
o
C.  
Two-dimensional Analysis of 30S and 30S-like Subunits 
The peak containing LiCl-treated RNA-protein complex was also examined on 2D 
gels, following a protocol derived from Geyl et al (1981)
116
 and modified by Lyon and 
Culver (unpublished data). In brief, LiCl treated subunits were isolated and precipitated 
using sodium acetate and ethanol. The samples were incubated at -20
o
C overnight and 
centrifuged at 10000 RPM for 30 minutes at 4
o
C.  Pellets were then re-suspended in 50µl 
deionized H2O. Mg-acetate/acetic acid was added to the mixture and centrifuged at 10000 
RPM for 30 minutes at 4
o
C.  To the supernatant, 5 volumes of acetone were added, the 
samples vortexed and precipitated at -20
o
C, centrifuged at 10000 RPM for 30 minutes and 
the pellets resuspended in deionized H2O. Samples were run on 2D gels (Biorad) and 
ribosomal proteins were stained using SYPRO Ruby protein gel stain (Biorad).  
Assembly of 70S from 30S LiCl-treated subunits and 50S ribosomal subunits was 
performed as follows: 30 pmols of 30S subunits (MRE600) from different LiCl treated 
concentrations (0M, 0.5M, 0.75M, and 1.0M LiCl) were incubated with 60 pmols of 50S 
ribosomal subunits (MRE600) at 37
 o
C for 1 hour in buffer containing 40mM Tris-HCl, pH 
7.5, 10 mM MgCl2, 100 mM NH4Cl, and 1 mM DTE.  Samples were loaded onto a 10-
40% sucrose gradient in a buffer containing 40mM Tris-HCl, pH 7.5, 10 mM MgCl2, 100 
mM NH4Cl, and 1 mM DTE and spun in an SW28 rotor at 19,000 rpm for 17 hours.  
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Competitors for ArmA Binding and Methylation of 30S subunits 
 The structural basis of aminoglycoside binding to the ribosomal A site has been 
studied by X-ray crystallography and NMR
40,45
. The NMR studies, showing the interaction 
between the aminoglycoside gentamicin and 27 nucleotides that correspond to the E.coli 
16S rRNA in the region of the A site (Figure 38A), highlighted the hydrogen bond 
between residue G1405 and the antibiotic. In addition, the crystal structure of an RNA 
fragment containing the A site (Figure 38B) bound to 4,6- disubstituted aminoglycoside 
geneticin reveals the detailed interaction between the A site and the antibiotic
37
 (Figure 
27C). Results obtained from these studies offer new insights for aminoglycoside - A site 
complexes. For our studies, it was of particular interest to note that  methylation by ArmA 
will disrupt the hydrogen bond between N7 of G1405 and the 3' amino group of 4,6- 
deoxystreptamine aminoglycosides and presumably cause steric hindrance between G1405 
and ring III of geneticin (Figure 38C). The methylation would also introduce a positive 
charge on the modified nucleotide, disfavoring the binding of the 4,6- disubstituted 
aminoglycosides, but not the 4,5- disubstituted group of aminoglucosides, to the decoding 
site.  
It has been observed that translationally active 30S ribosomal subunits are unable 
to bind 4,6-disubstituted aminoglycoside gentamicin as a result of G1405 methylation
61
. 
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Figure 38. The contacts between the A site and gentamicin. (A) The secondary structure of 
an oligonucleotide that corresponds to E. coli 16S rRNA in the region of the A site. The 
natural sequence is boxed in red; the ArmA modified nucleotide G1405 is shown in red
45
. 
(B) Secondary structure of the crystallized RNA fragment
40
. The two A sites are boxed in 
red. (C) The contacts between G1405 and 4,6 disubstituted aminoglycoside gentamicin 
(represented in pink). Hydrogen bonds are shown as dashed black lines.  
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Since we have shown that ArmA was able to methylate both translationally active and 
inactive 30S subunits (Chapter 2), we decided to further investigate if the structural 
changes between the two forms of 30S would extend to the gentamicin binding site. So, 
30S subunits were pre-incubated with various concentrations of gentamicin (0.01 mM, 0.1 
mM, and 1 mM) in both high [Mg
+2
] (8 mM) and low [Mg
+2
] (4 mM) reaction buffers. 
After the incubation time, ArmA was added to the solution and in vitro ArmA activity 
assay was measured (Figure 39). The results demonstrate that the presence of gentamicin, 
even at 0.01 mM, inhibits ArmA activity at both [Mg
+2
] concentrations. The antibiotic 
appears to bind to the low [Mg
+2
] form slightly better than to the high [Mg
+2
] form (Figure 
39), since we observe a greater decrease in ArmA activity at lower concentration of 
gentamicin in the presence of low [Mg
+2
].  
The results were not surprising considering that the inactive 30S conformation (low 
Mg
+2
) involves structural rearrangement of the 16S rRNA, where some nucleotides 
become more and some less surface exposed
69
. Changes in reactivity  toward probes that 
were used to monitor the accessibility of pyrimidines at N3 and purines at N-1 and N-7 
position in the active and inactive forms of 30S ribosomal subunits have been observed, 
mostly in the ‘decoding’ A- site at positions 1400 and 150069.  In particular, G1494 and 
U1495 (which are directly involved in gentamicin binding) are more exposed in the 
inactive conformation of 30S subunits, making them more accessible to the antibiotic. It is 
also possible that the A site by becoming less rigid in the inactive conformation, allows for 
easier conformational accommodation upon antibiotic binding. Subsequent direct binding 
experiments could be performed to test these observations. 
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Figure 39. Effect of gentamicin on ArmA activity. In vitro methylation of wild-type 30S in 
the presence of low (4 mM) or high (8 mM) Mg
+2 
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KsgA Effect on ArmA Activity 
     Kasugamycin resistance methyltransferase (KsgA) binds to the 30S ribosomal 
subunit in the decoding site and along helix 44, even though its sites for methylation (two 
adjacent adenosines 1518 and 1519) are located in helix 45
72
. Since the ArmA modified 
nucleotide G1405 lies in helix 44 and makes tertiary interactions with A1518, interference 
and mutual exclusivity of these two enzymes in binding at their target sites would be 
predicted. Our hydroxyl radical data suggested that some of the binding sites might be 
close to the KsgA binding sites on the 30S subunit (Figure 22).  
For these reasons, we tested whether KsgA inhibits ArmA methylation as a 
possible indicator of where ArmA binds to the 30S ribosomal subunit.  Since KsgA 
recognizes only the translationally inactive conformation of 30S ribosomal subunit
68
, 
caution needed to be taken when designing the experiment.  First, we measured ArmA 
methylation activity in the presence of KsgA at low (4mM) Mg
+2
 concentration, which 
stabilizes the translationally inactive conformation of 30S. To ensure that the transfer of 
methyl group measured in our assay was due to ArmA activity and not KsgA, we used 
catalytically inactive histidine-tagged KsgA (E66A)
117,118
 and 30S subunits prepared from 
the ksg
R
 strain described above.  The ksg
R
 30S subunits were pre-incubated with KsgA 
(E66A) for 10 minutes at 37
o
C prior to adding ArmA and 
3
H-methyl group incorporation 
from labeled SAM was measured at intervals over a 2 hour period (Figure 40). Our data 
show that in the presence of equimolar KsgA, methylation of translationally inactive (low 
[Mg
+2
]) 30S subunits by ArmA was reduced by 25%. Furthermore, in 10-fold excess 
KsgA, ArmA methylation activity was completely abolished. 
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Figure 40. In vitro methylation of 30S. (A)Time course competition assays of ArmA with 
KsgA E66A. Triangles indicate assays containing 10 pmol 30S ksg
R
 30S and 10 pmols of 
ArmA; diamonds indicate assays containing 10 pmol 30S ksg
R
 30S, 10 pmols of ArmA, 
and 10 pmols of KsgA E66A; squares indicate assays containing 10 pmol 30S ksg
R
 30S, 
10 pmols of ArmA, and 100 pmols of KsgA E66A; crosses indicate assays containing 10 
pmol 30S ksg
R
 30S and 10 pmols of KsgA E66A. 
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These results correlate well with our prediction that ArmA and KsgA share the same 
binding site, or at least that their binding sites overlap to some extent.  The conclusions of 
this experiment are qualified by the fact that the lower final counts seen in this in vitro 
assay might be due to the fact that the translationally inactive 30S subunits lacking the 
methylation at A1518 and A1519 used in this experiment are not the optimal substrate for 
ArmA.  
IF-3 effect on ArmA Activity  
Initiation factor 3 (IF3) and KsgA compete for binding to the 30S subunit
62
. Since 
KsgA and ArmA compete for the same site on the 30S subunit (Figure 40), we extended 
our competition experiments to determine whether the binding sites of IF3 and ArmA also 
overlap. We purified histidine-tagged IF3 and used it as a competitor in methylation assays 
for ArmA activity.  Wild type 30S subunits (10 pmols) were incubated with 10 pmols of 
IF3 in buffer containing 10 mM Mg
2+ 
for 10 minutes prior to addition of ArmA (Figure 
41). Our results show that IF3 did not have an inhibitory effect on methylation by ArmA, 
when compared to the control experiment where IF3 was not present in the reaction. 
Therefore, we conclude that the common locus for IF3 and KsgA binding does not 
intersect that for ArmA
72,93
. Indeed, our hydroxyl radical probing experiment (as well as 
the footprinting results for Sgm)
66
 did not show any cleavage sites at the 790 stem – loop, 
the most likely site shared by IF-3 and KsgA
72,93
. To ensure that the complex between IF3 
and 30S ribosomal subunit was formed, we used the same condition as for the in vitro 
activity assay and separated the complex using 10-30% sucrose gradient, which was 
checked on SDS PAGE gel for the presence of IF-3 (data not shown).                                          
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Figure 41. In vitro methylation of 30S. Time course competition assays of ArmA with IF-
3. Diamonds indicate assays containing 10 pmol 30S wild type and 10 pmols of ArmA; 
squares indicate assays containing 10 pmol 30S wild type, 10 pmols of ArmA, and 10 
pmols of IF-3.  
 
 
 
 
. 
  
96 
 
In vivo analysis  
Arm/Rmt activity is insensitive to the methylation status of A1518 and A1519 in 
vitro (Chapter 2), but it is possible that in vivo, where KsgA has a broader role in ribosome 
biogenesis beyond that of its methyltransferase function, it could affect Arm/Rmt 
methylation
76
.  To test for possible other effects of KsgA in vivo, we measured and 
compared MIC values of the antibiotic gentamicin in wild type and ΔksgA strains of E. coli 
in the presence and absence of RmtA, which was expressed under the control of an 
arabinose-inducible promoter (Table 2).  (The pBAD plasmid containing the RmtA was 
kindly provided to us by Matthew Baker). RmtA was overexpressed in the presence of 100 
µg/ml ampicillin, 64 µg/ml gentamicin, and either low (0.05%) or high (0.2%) arabinose. 
If there were no dependence of Arm/Rmt functions on KsgA in vivo, identical MIC values 
should be seen for the two strains.  A lower MIC in the ΔksgA strain, which corresponds to 
decreased gentamicin resistance, could be due to a partial dependence of RmtA activity on 
KsgA activity. We found a lower gentamicin MIC for the ΔksgA host under both low and 
high levels of RmtA (0.05% and 0.2% arabinose concentrations used to modulate RmtA 
expression).  In 0.05% arabinose the ΔksgA strain was more sensitive to gentamicin, with 
an MIC value of 32 μg/ml versus 256 μg/ml for wild type; similarly in 0.2% arabinose at 
higher RmtA concentrations the MICs for ΔksgA and wild type were 256μg/ml and 
512μg/ml.   
However, this observation cannot be ascribed to a direct interplay between KsgA 
and RmtA, since the control experiment done in the presence of arabinose and the absence 
of plasmid borne RmtA gave an MIC of 32 μg/ml for the wild type strain and 8 μg/ml in 
the ΔksgA strain.  Therefore, we conclude that there is probably no functional dependence  
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Table 2. In vivo activity assay 
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of RmtA on KsgA in vivo under the conditions examined here and that ΔksgA has an 
inherent increased gentamicin sensitivity arising from other causes. 
To further explore the difference in sensitivity between the wild type and ΔksgA 
strains toward various groups of aminoglycosides, we tested the Keio cells in the absence 
of RmtA (Table 3). We noticed increased sensitivity toward the 4,6 disubstituted 
aminoglycosides (tobramycin and amikacin),but decreased sensitivity toward  the 4,5 type 
of aminoglycosides (neomycin and paromomycin).  As expected, we did not see a 
difference in sensitivity between the two strains when streptomycin was used, since this 
antibiotic has a completely different structure and binding mode
34
.   
To test whether RmtA can overcome the higher gentamicin sensitivity of the 
ΔksgA mutant, we did serial dilutions of E. coli carrying the RmtA plasmid and monitored 
cell growth for wild type and ΔksgA strains in the presence of 64 µg/ml of gentamicin 
(Figure 42). At high RmtA (0.2% arabinose), the two strains showed only slight difference 
in gentamicin sensitivity. However, at low RmtA (0.05% arabinose) we observed a 
pronounced growth defect in the ΔksgA strain compared to the parental strain. From our 
experiments, we conclude that RmtA can overcome the inherent increased gentamicin 
sensitivity in the ΔksgA strain, but only at high levels.  Our in vivo studies show that ArmA 
likely has a relatively narrow temporal window on the ribosome maturation pathway, but a 
wider window of conformational conditions in which to transfer the methyl group to 
G1405. 
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Table 3. MIC towards different aminoglycoside in Keio cells.  
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Figure 42. Overexpression of RmtA in the wild-type and ΔksgA Keio cells. Plating 
experiment of saturated culture diluted in ten-fold increments and plated on LB plates 
containing 100 µg/ml ampicillin, 64 µg/ml gentamicin, and either 0.2% or 0.05% arabinose 
at 37
o 
C. 
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Conclusions 
We have shown that the differences between active and inactive 30S ribosomal 
subunit states do not affect ArmA access to G1405 (Chapter 2).  This finding was further 
reinforced by the abolition of ArmA activity in the presence of gentamicin at both high and 
low [Mg
+2
].  The result obtained here also implies that the gentamicin binding site, in 
which G1405 lies, is not greatly affected in either low or high Mg
+2
 30S forms. We also 
observed a slightly greater decrease in ArmA activity at lower concentration of gentamicin 
in the presence of low [Mg
+2
], indicating that some very subtle changes in the 30S subunit 
(between the active and inactive forms) can affect association of the antibiotic with the A 
site.  
We also showed inhibition of ArmA methylation by pre-bound KsgA at low 
[Mg
+2
], which indicates overlap of the binding sites of KsgA and ArmA.  However, this 
conclusion is qualified by the requirement for some conformational change in 30S subunit 
for ArmA to access G1405.  The conformational excursion for binding both KsgA and 
ArmA may be the same and each enzyme could be binding to a part of the 16S rRNA 
which is not accessible in the static, crystallographically determined 30S subunit structure. 
A similar case is found in the sisomicin-gentamicin resistance methyltransferase Sgm, an 
ortholog of ArmA, which methylates G1405 in the A site and requires conformational 
change in order to access the buried target nucleotide
66
.    
In contrast, the presence of IF3 did not affect the binding of ArmA to the 30S 
subunit, indicating that the binding sites for ArmA and IF3 do not overlap. Furthermore, 
we can conclude that the common locus for IF3 and KsgA binding does not intersect that 
for ArmA.  
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Experimental  
 
Proteins and 30S Subunit Expression and Purification 
Proteins and 30S subunits were expressed and purified as described in Chapter 2. 
pBAD/RmtA construct was kindly provided by Matthew Baker.  
Expression and purification of mutant E. coli KsgA and IF3 
The pET25b-KsgA and pET28b-IF3 constructs were kindly provided by Dr. 
Heather O’Farrell and Dr. Matthew Hartman of VCU and were confirmed by sequencing. 
Proteins were expressed in BL21 (DE3) cells (Stratagene) grown at 37°C to an OD600 of 
0.6 in the presence of ampicillin (for KsgAE66A) or kanamycin (for IF3). Protein 
expression was induced with 0.1 mM IPTG and the cultures grown for a further 4 h. Cells 
were harvested and broken as for ArmA and KsgAE66A was purified on a HiTrap Ni
+2
 
chelated column equilibrated with 50 mM NaPO4, pH 8.0, 300 mM NaCl, 10 mM 
imidazole.  KsgAE66A was eluted with the same buffer containing 250 mM imidazole. IF-
3 was purified as previously described
119
.  Cells were lysed in 20 mM Tris- HCl, pH 7.7, 
60 mM NH4Cl, 10 mM MgCl2, 10% Glycerol, 5 mM BME, 0.1 mM PMSF and 0.1 mM 
benzamidine and the cleared lysate loaded onto a HiTrap Ni
+2
 column.  IF-3 was eluted 
with 20mM Tris-HCl, pH 7.7, 10 mM MgCl2, 10% Glycerol, 5 mM BME, 0.1 mM PMSF, 
0.5 mM EDTA, and 0.3M imidazole.  All proteins were estimated to be >95% pure by 
SDS-PAGE analysis.  
In vitro Activity Assay 
In vitro activity assay was performed as described in Chapter 2.  
 
  
103 
 
In vivo analysis 
Keio wild type and ΔksgA cells were grown in LB media and ampicillin (100 
µg/ml) at 37
o
 C overnight. Saturated cultures were inoculated in LB media in presence of 
either low (0.05 %) or high (0.2 %) arabinose and ampicillin (100 µg/ml) until they 
reached OD550 of 0.7-0.8. Cultures were diluted in tenfold increments and 5 µl was spotted 
on LB plates containing 100 µg/ml ampicillin, 64 µg/ml gentamicin, and 0.05% (or 0.2 %) 
arabinose. Plates were incubated at 37
o
 C overnight.  
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Conclusions and Future Work 
The outlines of E .coli ribosome biogenesis were elaborated by Nomura and 
Nierhaus 
13, 120
, but new levels of complexity have been recognized in the overall 
process in recent years
76
, particularly since the determination of high resolution crystal 
structures of the ribosome and its subunits and complexes
40,45
.  Transcription and 
processing of pre-16S rRNA is coordinated with association of both ribosomal and 
transiently bound proteins, including RNA modification enzymes.  While the overall 
pathway leading to assembly of the mature ribosome is regulated and clearly ordered, 
there is evidence for parallel sequences of steps that converge downstream in the 
process
1,121
.  
Bacterial resistance to 4,6-type aminoglycoside antibiotics, which target the 
small ribosomal 30S subunit, has been traced to the arm/rmt family of rRNA 
methyltransferases isolated from various pathogens. These plasmid-encoded enzymes 
transfer a methyl group from S-adenosyl-L-methionine to N7 of the buried G1405 in 
the aminoglycoside binding site of 16S rRNA in the 30S ribosomal subunit.  We have 
characterized aminoglycoside resistance methyltransferase (armA), and obtained 
significant information regarding its mode of action. ArmA methylates mature 30S 
subunits but not 16S rRNA, 50S or 70S ribosomal particles or isolated Helix 44 of the 
30S subunit
61
.  To further explore this family of enzymes, we have investigated the 
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substrate requirements of ArmA.  We determined the Mg
2+
 dependence and found that 
ArmA could recognize both translationally active and translationally inactive 30S 
ribosomal subunits.  
We tested the effects of kasugamycin resistance methyltransferase (KsgA) and 
initiation factor 3 (IF3) binding to 30S subunits on ArmA activity.  The inhibition of 
ArmA methylation by pre-bound KsgA at low [Mg
+2
] indicates overlap of the binding 
sites of KsgA and ArmA.  However, this conclusion is qualified by the requirement for 
some conformational change in 30S subunit for ArmA to access G1405.  In contrast, 
IF3 showed no effect on methylation by ArmA, from which we concluded that the 
common locus for IF3 and KsgA binding does not intersect that for ArmA
72
. We also 
tested LiCl treated 30S particles and in vivo derived pre-30S ribosomal subunits as 
ArmA methylation substrates. From these experiments, we conclude that ArmA is most 
active toward 30S ribosomal subunits that are at or very near full maturation.   
However, additional biochemical studies have to be performed in order to fully 
understand this group of enzymes. Mutations of active site residues would be the first 
step to explore. This would elucidate the role of residues important for SAM binding 
and for target guanosine binding. The binding studies could be performed using the 
ITC method for SAM binding, since we were able to measure the binding of wild-type 
ArmA and SAM using this technique. Once we identify mutant(s) which are able to 
bind 30S subunits but are not catalytically active, we could repeat the binding studies 
for ArmA and 30S subunits. This would help us better understand the complex ArmA 
mechanism and complete the binding studies for each substrate. Another outstanding 
question we would like to address involves the order (if any) of substrate binding. It 
would be of interest to know if the binding of one substrate requires a conformational 
change of 30S subunits that creates the binding site for the second substrate. These 
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studies would involve crystallizing ArmA (or its homologs) with both substrates, 30S 
subunit and SAM. It should be noted that only two structures of methyltransferases in 
complex with their respective RNA substrates have been determined
105,106
.  Strenuous 
efforts are therefore required to perform structural studies of ArmA binding to the A 
site of 30S ribosomal subunits. In addition, it would be interesting to further explore 
the assembly state of pre-30S ribosomal subunits required for efficient methylation by 
ArmA. For those experiments, we could use well established in vitro reconstitution 
assays and in vivo gene knock-out assays to define the structural and assembly state 
requirements of 30S subunits for ArmA.  
All of the aforementioned studies would help us achieve a long term goal – to 
develop Arm/Rmt specific inhibitors that will not interfere with other physiologically 
important m
7
G methylations
122,123
.  Since other m
7
G methyltransferases
123 
 have a 
different mode of protein-ligand interaction from that of ArmA, the design of inhibitors 
against the medically important ArmA family of methyltransferases is somewhat 
simplified. Domains specific for this family of methyltransferases could be considered 
as targets for particular inhibitors.  
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